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Abstract 
  Salmonella enterica is capable of utilizing 1,2-propanediol (1,2-PD) as a sole carbon 
and energy source in a coenzyme B12 (Adenosylcobalamin, AdoCbl) -dependent fashion 
that involves a bacterial microcompartment (MCP), the Pdu MCP. Pdu MCP is a 
polyhedral organelle composed entirely of protein subunits and its function is to sequester 
the intermediate propionaldehyde formed in the first step of 1,2-PD degradation in order 
to mitigate its toxicity and prevent DNA damage. Several sequentially-acting metabolic 
enzymes, including the diol dehydratase PduCDE and the propionaldehyde 
dehydrogenase PduP that respectively use AdoCbl and NAD+ as cofactors, are 
encapsulated within the solid protein shell of the MCP. During catalysis, the 
adenosyl-group of AdoCbl bound to PduCDE is periodically lost due to by-reactions and 
is usually replaced by a hydroxo-group resulting in the formation of an inactive 
OH-Cbl-enzyme complex, and the NAD+ is converted to NADH by PduP, which make it 
necessary to regenerate or/and replenish AdoCbl and NAD+ within the Pdu MCPs. 
Recent crystallography studies suggested that some Pdu MCP shell proteins, such as 
PduA, T and U, have pores that may mediate the transport of enzyme substrates/cofactors 
across the MCP shell. However, it’s possible that the cofactors might be regenerated in 
the local vicinity of the metabolic enzymes within the MCP, which could contribute to 
higher activity of the enzymes and thus to higher efficiency of 1,2-PD degradation.  
In this work, two proteins encoded by the pdu locus consisting of genes specifically 
involved in 1,2-PD utilization, PduS and PduQ, were overexpressed, purified and 
characterized in vitro, and their in vivo fuctions were investigated as well.  
Purified PduS enzyme exhibited the abilities to catalyze the two successive 
uni-electron reductions from cob(III)alamin to cob(I)alamin in vitro. The results indicated 
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that PduS is a monomer and each monomer of PduS contains one non-covalently bound 
FMN and two [4Fe-4S] clusters which are oxygen-labile. Genetic studies showed that a 
pduS deletion decreased the growth rate of Salmonella on 1,2-PD supporting a role in 
cobalamin reduction in vivo. Further SDS-PAGE and Western blot of purified Pdu MCP 
and following MS-MS analysis demonstrated that the PduS protein is a component of the 
Pdu MCP. In addition, two-hybrid experiments indicated that PduS interacts with the 
PduO adenosyltransferase which is also located in the Pdu MCP and catalyzes the 
terminal step of AdoCbl synthesis. 
Purified PduQ enzyme was identified as an oxygen-sensitive iron-dependent alcohol 
dehydrogenase (ADH) that catalyzes the interconversion between propionaldehyde and 
1-propanol in vitro. The propionaldehyde reduction activity of PduQ was about 45 times 
higher than that of the 1-propanol oxidation at pH 7.0, indicating that this enzyme is more 
efficient for catalyzing aldehyde reduction in cells where approximatedly neutral pH is 
maintained. Kinetic studies indicated PduQ has a high affinity for the substrate and 
cofactor involved in this reduction reaction, which also suggest that the physiological 
function of PduQ is the reduction of aldehyde with the conversion of NADH to NAD+. 
The pduQ deletion impaired growth on 1,2-PD and led to a lower cell density, indicating 
that PduQ was required to support the maximal rate of 1,2-PD degradation by Salmonella. 
SDS-PAGE and Western blot of purified Pdu MCP and subsequent MS-MS analysis 
demonstrated that the PduQ protein is also associated with the Pdu MCP. Co-affinity 
purification illustrated a specific strong interaction between PduQ and PduP. 
In conjunction with prior results, this work indicates that the Pdu MCP encapsulates a 
complete AdoCbl recycling system and that it is able to recycle the electron carrier NAD+ 
as well within the MCP lumen.  
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Chapter 1. General introduction 
1.1. Vitamin B12 
Vitamin B12 is also known as cobalamin (Cbl). In a broad sense, B12 refers to a group 
of cobalt-containing vitamer compounds including cyanocobalamin (CN-Cbl), 
hydroxocobalamin (OH-Cbl), and the two coenzyme forms of B12: 
5'-deoxyadenosylcobalamin (adenosylcobalamin, AdoCbl), and methylcobalamin 
(MeCbl). The term B12 may be properly used to refer to cyanocobalamin, the principal 
B12 form used for foods and in nutritional supplements. 
Vitamin B12 is the most chemically complex of all the vitamins. The structure of B12 is 
based on a corrin ring, which is similar to the porphyrin ring found in heme, chlorophyll, 
and cytochrome. De novo synthesis of B12 occurs only in certain bacteria and archaea but 
the assimilation of complex precursors is more widespread taking place in many 
microorganisms and in higher animals (202). Vitamin B12 is an essential cofactor for a 
variety of enzymes that are widely distributed among microorganisms and higher animals 
(14, 203). Plants and fungi are thought to neither synthesize nor use B12 in their 
metabolism (70). 
Vitamin B12 is naturally found in foods of animal origin including meat and milk 
products. Non-ruminant animals must obtain B12 in their diet.  
1.1.1. Discovery and structure of vitamin B12  
Vitamin B12 was discovered by accident in medicine. B12 deficiency is the cause of 
pernicious anemia, an anemic disease that was usually fatal and had unknown etiology 
when it was first described by Combe in 1824 (80). In 1925, Whipple and co-worker 
showed that the regeneration of red blood cells in anemic dogs induced by bleeding was 
stimulated by a diet containing liver (182), and in 1926 Minot and Murphy reported a 
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remarkable improvement in patients fed a diet of raw liver (152). This clue started the 
search for the “liver factor” or “anti-pernicious anemia factor”. In 1928, Edwin Cohn 
prepared a liver extract that was 50 to 100 times more potent than the natural liver 
products (56). The extract was the first workable treatment for the disease. These events 
in turn led to discovery of the water soluble vitamin, called vitamin B12, in the liver juice 
in 1948 by Karl A. Folkers (181) and E. Lester Smith (212). In 1955, the B12 structure 
was elucidated by X-ray crystallographic analysis in the laboratory of Dorothy Hodgkin 
(102).  
 
B A 
 
 
 
FIG. 1.1. The structure of vitamin B12. A, Structural formula of vitamin B12; B, Stick model of vitamin 
B12; C, The various ligation states of cobalamin derivatives (17). 
C 
The structure of tetrapyrrolic vitamin B12 is shown in Figure 1.1. B12 has three parts: a 
central ring, an upper ligand, and a nucleotide loop. The upper ligand is a cyano (CN-) 
group that can be replaced by a hydroxo (OH-), methyl (CH3-), or 5’-deoxyadenosyl 
(Ado-) group. The central cobalt atom coordinatively binds to the four equatorial nitrogen 
ligands of the corrin ring. Attached to a carbon of the corrin ring is a nucleotide side chain 
terminated by a 5,6-dimethylbenzimidazole (DMB) group, which may act as an axial 
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ligand toward the cobalt atom. Cobalamin complexes in which the DMB is bound to the 
cobalt atom are usually named base-on forms, whereas if such coordination is absent or 
replaced by an exogeneous ligand the designation base-off is used (Fig. 1.1C).  
The cobalt atom in cobalamins can exist under three main formal oxidation states, Co+3, 
Co+2, and Co+1, which display quite different chemical properties. Roughly speaking, 
Co+3 appears as an electrophile, Co+2 as a radical, and Co+1 as a nucleophile. 
Oxidoreductive conversions between the three oxidation states are thus of key importance 
in the chemistry of vitamin B12. When the oxidation state of the cobalt atom decreases its 
coordination number tends to decrease accordingly.  
1.1.2. Biosynthesis of vitamin B12 
According to a widely accepted historical view, B12 de novo synthesis is restricted to 
some bacteria and archaea (202). Many animals, including humans, and protists require 
B12 but apparently do not synthesize it de novo. Plants and fungi are thought to neither 
synthesize nor use B12 in their metabolism (70).  
1.1.2.1. De novo synthesis 
Vitamin B12 is synthesized de novo via two alternative routes, aerobic and anaerobic 
pathways that differ primarily in the early stages that lead to the contraction of the 
macrocycle and excision of the extruded carbon molecule and its attached methyl group 
(183) (Fig. 1.2). The aerobic pathway, which has been determined experimentally in 
Pseudomonas denitrificans (206), incorporates molecular oxygen into the macrocycle as a 
prerequisite to ring contraction. The anaerobic route, which has been most extensively 
studied in Salmonella enterica serovar Typhimurium LT2 (referred to hereafter as S. 
enterica) (189), takes advantage of a chelated cobalt ion, in the absence of oxygen, to set 
the stage for ring contraction.  
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FIG. 1.2. Biosynthesis of precorrin 6 (aerobic pathway; light arrows) and cobalt-precorrin 6 
(anaerobic pathway; bold arrows) on the route from ALA to vitamin B12 (206). The two pathways are 
identical from ALA to precorrin 2, at which point they diverge as shown. PBG, porphobilinogen; HMB, 
hydroxymethylbilane; SAM, S-adenosyl-L-methionine. 
The biosynthetic route to AdoCbl from its five-carbon precursor, 5-aminolaevulinic 
acid (ALA) may be divided into three sections: (1) the biosynthesis of uroporphyrinogen 
III (UroIII) from ALA, which is shared by both pathways (Fig. 1.2); (2) the conversion of 
UroIII into the ring-contracted, deacylated intermediate (precorrin 6 or cobalt-precorrin 6), 
wherein lies the primary differences between the two pathways (Fig. 1.2); and (3) the 
transformation of this intermediate to AdoCbl (Fig. 1.3). 
First, UroIII, which is also an intermediate during heme, chlorophyll, F430, and 
siroheme synthesis, is biosynthesized through a common pathway from ALA utilizing the 
enzymes ALA dehydratase (HemB), porphobilinogen deaminase (HemC) and UroIII 
synthase (HemD) (Fig. 1.2) (206).  
Next, UroIII is converted into precorrin 6 (aerobic) or cobalt-precorrin 6 (anaerobic) 
(Fig. 1.2). The aerobic pathway requires five S-adenosyl-L-methionine (SAM) 
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-dependent methyltransferases (CobA, I, J, M, F) for the introduction of six methyl 
groups and is characterized by the incorporation of molecular oxygen by a 
monooxygenase (CobG). The anaerobic pathway also requires five methyltransferases 
(CysG, CbiK or X, CbiL, H, F), and is distinguished by the early incorporation of cobalt 
into the macrocycle.  
 
FIG. 1.3. Aerobic pathway from precorrin 6 to AdoCbl (206). SAM, S-adenosyl-L-methionine; Ado-, 
adenosyl. 
Lastly, precorrin 6 or cobalt-precorrin 6 is converted into AdoCbl. The known pathway 
and enzymes necessary for the conversion of precorrin 6 into AdoCbl in the aerobic 
pathway are shown in Figure 1.3. The structures of the intermediates of the anaerobic 
pathway between cobalt-precorrin 6 and AdoCbl are believed to the same as those of the 
aerobic pathway, with the exception that, since the cobalt ion is already in place, 
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dihydro-precorrin 6, precorrin 8 and hydrogenobyrinic acid are replaced with the 
corresponding cobalt complexes. Thus, in the anaerobic pathway, hydrogenobyrinic acid 
is replaced by cobyrinic acid, which then is the substrate for bisamidation to afford 
cob(II)yrinic acid a,c-diamide. All of the ensuing intermediates are identical in the aerobic 
and anaerobic pathways. 
1.1.2.2. Assimilation and recycling 
De novo synthesis occurs only in prokaryotes but the assimilation of complex 
precursors is more widespread taking place in many microorganisms and in higher 
animals (202). A model for the assimilation of CN-Cbl and OH-Cbl to AdoCbl, based on 
work done in a number of laboratories, is shown in Figure 1.4. CN-Cbl is first reductively 
decyanated to cob(II)alamin (91, 119, 238). Next, cob(II)alamin is reduced to 
cob(I)alamin and ATP:cob(I)alamin adenosyltransferase (ATR) transfers a 
5'-deoxyadenosyl-group from ATP to cob(I)alamin to form AdoCbl (39, 42, 111, 113, 131, 
215, 221, 248). OH-Cbl assimilation occurs by a similar pathway except that the first step 
is reduction of OH-Cbl to cob(II)alamin by cobalamin reductase or by the reducing 
environment of the cell (82, 239). 
 
 
FIG. 1.4. Proposed pathway from CNCbl to AdoCbl (adapted from ref. (195)).  
The pathway used for the assimilation of OH-Cbl and CN-Cbl is also used for 
intracellular cobalamin recycling. During catalysis the adenosyl-group of AdoCbl is 
periodically lost due to by-reactions and is usually replaced by a hydroxo-group resulting 
in the formation of an inactive OH-Cbl-enzyme complex (228). Cobalamin recycling 
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begins with a reactivase that converts inactive OH-Cbl-enzyme complex to OH-Cbl and 
apoenzyme (154, 155). Next, the process described in Figure 1.4 converts OH-Cbl to 
AdoCbl, which spontaneously associates with apoenzyme to form active holoenzyme 
(154, 155, 228). In the organisms that have been studied, cobalamin recycling is essential, 
and genetic defects in this process block AdoCbl-dependent metabolism (17, 66, 113). 
1.1.3. Absorption, transport and cellular uptake of vitamin B12 
Cobalamins cannot be synthesized by higher organisms and must be supplied with the 
diet. Mammals have developed a complex pathway, sketched on the left side of Figure 1.5, 
for absorption, transportation and cellular uptake of cobalamin.  
 
FIG. 1.5. Absorption, transport and cellular uptake of cobalamins in mammals (177).  
This pathway involves three separate binding proteins, haptocorrin (HC), intrinsic 
factor (IF) and transcobalamin (TC), which form tight complexes with Cbl (4, 190). The 
dietary Cbl is preferentially bound to salivary HC to form the complex HC-Cbl. 
Pancreatic proteases in the duodenum cleave HC, Cbl is released and then binds to IF 
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forming IF-Cbl (5). Inside the enterocytes, the IF is degraded and the free Cbl binds to TC. 
The TC-Cbl complex is then released into plasma, where it is endocytosed by membrane 
receptors, R-TC-Cbl (161, 174) (Fig. 1.5, left side). Inside the target cells, TC-Cbl is 
degraded into lysosomes, releasing cobalamin molecules which are metabolized to the 
two cofactors: 5’-deoxyadenosyl-Cbl in mitochondrion and methyl-Cbl in cytosol (Fig. 
1.5, right side) (13). 
 
FIG. 1.6. Hypothetical scheme of cobalamin uptake in E. coli (177). The proteins involved in the 
transport and B12 cellular uptake, whose X-ray structures are available, are shown by the ribbon 
representation for the protein moiety and by stick and ball for cobalamin. The X-ray structures of 
OmpF, ExbB and ExbD have not been determined and are indicated by a colored form.  
In E. coli (and other Gram-negative bacteria), a hypothetical representation of the Cbl 
import across the membrane (38) is sketched in Figure 1.6. The B12 transmembrane 
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import is accomplished by the B12-uptake (Btu) system, consisting of an outer membrane 
transporter BtuB (Fig. 1.6, left side) and an ATP-binding cassette (ABC) transporter, 
BtuC2D2F, located in the inner membrane (Fig. 1.6, right side). It is proposed that Cbl is 
taken up by BtuB, located in the outer membrane, and then released in the periplasmatic 
space (Fig. 1.6, left side). In the periplasmatic space Cbl is bound to BtuF and the 
resulting BtuF-Cbl complex binds to the periplasmatic side of BtuC2D2, located in the 
inner membrane (Fig. 1.6, right side), and feeds Cbl to the latter. The hydrolysis of ATP, 
located between the two BtuD domains powers the import of Cbl in the E. coli cells.  
1.1.4. Function of vitamin B12 
Vitamin B12 is an indispensable organometallic cofactor associated with a variety of 
enzymes that are widely distributed among microorganisms and higher animals (14, 203). 
Based on the reaction mechanisms, the enzymes are divided into three classes: 
AdoCbl-dependent isomerases, MeCbl-dependent methyltransferases, and 
corrinoid-dependent reductive dehalogenases, which catalyze intramolecular 
rearrangement, methyl group transfer, and reductive dehalogenation, respectively. 
1.1.4.1. AdoCbl-dependent intramolecular rearrangement 
The isomerases are the largest subfamily of AdoCbl-dependent enzymes found in 
bacteria. In enteric bacteria, they play important roles the B12-dependent degradation of 
ethanolamine, propanediol, and glycerol (Fig. 1.7), which may be the earliest use of B12 
(15, 16, 145). In these reactions, the B12-mediated rearrangement generates an aldehyde 
that can be oxidized and provide ATP; the oxidations can be balanced by reducing a 
portion of the aldehyde to an alcohol. In nonenteric bacteria, the AdoCbl -dependent 
amino mutases (specific for glutamate, lysine, leucine, or ornithine) catalyze 
mechanistically similar reactions that support fermentation of these amino acids.  
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FIG. 1.7. AdoB12-dependent enzymes involved in fermentative degradation in enteric bacteria (188). 
Only the first reaction for each pathway employs cobalamin as a cofactor. 
The AdoCbl-dependent methylmalonyl-CoA mutase (MCM or MUT), which is found 
in both bacteria and higher animals, catalyzes the isomerization of 
(R)-methylmalonyl-CoA and succinyl-CoA during the catabolism of branched-chain 
amino acids, thymine, uracil, cholesterol, and odd-chain fatty acids (76) (Fig. 1.8). 
 (R)-methylmalonyl-C succinyl-CoA oA 
MUT 
FIG. 1.8. Isomerization of (R)-methylmalonyl-CoA and succinyl-CoA catalyzed by 
methylmalonyl-CoA mutase. 
In some organisms, an AdoCbl-dependent ribonucleotide reductase (class II) catalyzes 
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the conversion of ribonucleotides to deoxyribonucleotides (Fig. 1.9), which is 
fundamentally important for DNA replication and repair (18).  
 
FIG. 1.9. The reaction catalyzed by class II ribonucleotide reductase (18). 
In the above enzymes, AdoCbl acts as a free radical generator. The general catalytic 
mechanism is shown in Figure 1.10. The reaction begins with homolytic rupture of the 
C-Co(III) bond of AdoCbl. The C and Co atoms each acquire one electron, leading to the 
formation of cob(II)alamin and the deoxyadenosyl radical (step 1). This is followed by 
hydrogen atom (H-atom) abstraction from the substrate by the deoxyadenosyl radical to 
generate a reactive primary substrate radical (step 2). Rearrangement generates a 
secondary product-centered radical (step 3). Finally, a second H-atom transfer from 
deoxyadenosine yields product (step 4), and recombination of the cofactor centered 
radical pair (step 5) completes a turnover cycle. The catalytic mechanism of class II 
ribonucleotide reductase is a bit different from the general mechanism described above in 
that a thiyl radical rather than the initially formed 5′-deoxyadenosyl radical abstracts a 
hydrogen atom from the substrate and reduction occurs at C2′ of the substrate in class II 
ribonucleotide reductases (Fig. 1.9).  
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1 
2 
3 
4 
5 
FIG. 1.10. The reaction mechanism catalyzed by AdoCbl enzymes (CH2-R = Ado) (177).  
1.1.4.2. MeCbl-dependent methyl group transfer 
The MeCbl-dependent methyltransferases play an important role in amino acid 
metabolism in many organisms including humans as well as in one-carbon metabolism 
and CO2 fixation in anaerobic microorganisms (18). As a subclass of the group transfer 
enzymes, MeCbl-dependent methyltransferases catalyze the movement of a methyl group 
from a methyl donor (X-CH3) to a methyl group acceptor (Nuc) (Fig. 1.11), where X and 
Nuc are the leaving group and the nucleophile, respectively (18). In these 
methyltransferases, MeCbl is cleaved heterolytically and acts as a methyl group carrier.  
 
FIG. 1.11. Methyl donors and acceptors used by the B12-dependent methyltransferases (18).  
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Methionine synthase (MS) from Escherichia coli (MetH) is the most extensively 
studied B12-dependent methyltransferase that transfers a methyl group from 
5-methyltetrahydrofolate (CH3-THF) to homocysteine to form methionine and 
tetrahydrofolate (THF) at the final step in methionine biosynthesis (Fig. 1.12) (69, 73). 
The MeCbl-dependent methionine synthase works in two steps in a ping-pong reaction 
(73) (Fig. 1.12). First, MeCbl is formed by a methyl group transfer from N5-CH3-THF 
with formation of MeCbl and THF. In the second step, MeCbl transfers this methyl group 
to homocysteine, regenerating the cofactor cobalamin and releasing the product 
methionine.  
 
FIG. 1.12. Methionine synthesis catalyzed by MeB12-dependent methionine synthase (73). 
In many anaerobic bacteria, methyl-corrinoids are involved in acetyl-CoA synthesis via 
the Wood-Ljungdahl pathway (176, 220, 243) (Fig. 1.13A). In this pathway, a methyl 
group is transferred from CH3-THF via a methyl-corrinoid/iron sulfur protein to 
CO-dehydrogenase, which synthesizes acetyl-CoA from this methyl group, CO, and 
coenzyme A (77). A corrinoid plays an analogous role in the energy-yielding metabolism 
of acetogenic bacteria, which synthesize acetate from 2 CO2 as a means of generating a 
 
 
14 
 
terminal electron sink (176). 
Methyl-corrinoids are also essential for formation of methane by the strictly anaerobic 
methane-producing archaea (220) (Fig. 1.13B). Corrinoid proteins play a role in the 
transfer of methyl groups from methanogenic substrates to the thiol group of the 
methanogen-specific cofactor, coenzyme M. Different enzymes mediate methyl transfer 
from alternative methanogenic substrates such as acetate (78), methylamines (44), 
methanol, pyruvate (33) and methyltetrahydromethanopterin (CH3-H4MPT), an 
intermediate of methanogenesis from formate and CO2 (169). The latter reaction is 
analogous to methionine synthesis in that the methyl group is transferred from an 
intermediate pterin to a thiol group via MeCbl by an integral membraneme thyltransferase 
(169). Considerable energy is released by transfer of a methyl group to coenzyme M from 
CH3-H4MPT (93, 220). The energy of the transfer to coenzyme M can be recovered by 
coupling the methyl transfer to extrusion of a sodium ion, which eventually leads to 
generation of a proton motive force (19).  
 
FIG. 1.13. Methyltransferases involved in anaerobic CO2 fixation and energy metabolism (18). A The 
Wood-Ljungdahl Pathway. B MeCbl-dependent methyltransferases in methanogenesis. ACS, 
acetyl-CoA synthase; CODH, CO dehydrogenase; CFeSP, corrinoid iron-sulfur protein; and MeTr, 
AcsE-methyltransferase. 
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1.1.4.3. Corrinoid-dependent reductive dehalogenation 
Bacterial reductive dechlorination reactions play important roles in the detoxification 
of chlorinated aromatic and aliphatic compounds in contaminated environments (101, 
135). Both aerobic and anaerobic microorganisms can perform dehalogenation; however, 
anaerobic bacteria are more efficient in removing halogen atoms from polyhalogenated 
compounds (71). 
Several anaerobic bacteria use chlorinated compounds as growth-supporting electron 
acceptors in their energy metabolism, coupling reductive dehalogenation to electron 
transport phosphorylation (103, 140). Reductive dehalogenases catalyzing the reductive 
dechlorination of chlorinated ethenes, phenols, or benzoates have been isolated from 
several species (54, 142, 150, 160, 162, 205): 
R-Cl + 2e- + 2H+ → RH + HCl  
There are two major classes of anaerobic dehalogenases: the heme containing 
3-chlorobenzoate reductive dehalogenase from Desulfomonile tiedjei (162) and the 
vitamin B12-dependent enzymes such as that from Desulfitobacterium chlororespirans 
(123). The B12-dependent reductive dehalogenases, most of which also contain iron-sulfur 
clusters, are either embedded in or attached to the membrane by a small anchoring protein. 
This membrane association is important in linking the dehalogenation reaction to the 
electron transport pathway of anaerobic respiration. A few B12-dependent dehalogenases 
have been purified, including the haloalkane (perchloroethylene and trichloroethene) 
dehalogenases from Desulfitobacterium strain PCE-S (150) and the 
3-chloro-4-hydroxy-phenylacetate dehalogenases from Desulfitobacterium hafniense (54). 
These proteins contain a corrinoid, a [4Fe-4S] cluster, and a [3Fe-4S] cluster per 
monomeric unit. Multiple dehalogenases are evident in the genome sequence of D. 
hafniense strain DCB-2. Thus, the ability of certain dehalorespiring microorganisms to 
 
 
16 
 
metabolize various types of chlorinated organic compounds (e.g., chloroalkanes plus 
chlorobenzoates) is conferred by separate (but homologous) enzymes (232). 
 
FIG. 1.14. Alternative mechanisms for corrinoid-dependent reductive dehalogenation (18). 
The role of B12 in the reductive dehalogenases appears to be significantly different 
from those of the AdoCbl-dependent isomerases and the MeCbl-dependent 
methyltransferases. Mechanistic studies on the anaerobic dehalogenases have lagged 
behind studies on the aerobic enzymes. Two working models for the mechanisms of 
dehalorespiring reductive dehalogenases are shown in Figure 1.14. In Path A, an 
organocobalt adduct is formed as in the methyltransferases. In Path B, the corrinoid 
serves as an electron donor. In Path A, the halide is eliminated as the aryl-Co(III) 
intermediate is formed. Path B resembles the Birch reduction of hydroxylated aromatics 
in which a radical anion is formed. Both mechanisms assume that the corrinoid is the site 
of dehalogenation based on the ability of B12 to catalyze dehalogenation in solution (124) 
and light-reversible inhibition by propyl iodide, a characteristic of corrinoid-dependent 
reactions (149, 159).  
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1.1.5. Vitamin B12-related diseases 
There are two B12-dependent reactions in the human body: methionine synthase and 
methylmalonyl-CoA mutase.  
Methionine synthetase, a methyl transferase, is presumed to be important primarily in 
recycling folate and secondarily in producing methionine (3). Methionine synthase is the 
only enzyme present in higher animals that uses CH3-THF as a substrate. Thus, a defect in 
methionine synthase or B12 traps folate as CH3-THF resulting in a subsequent deficiency 
of THF. Since THF is an indispensible cofactor functioning in synthesis of purines and 
pyrimidines, the lack of this reaction underlies many aspects of human B12-deficiency 
disorders including pernicious anemia and megaloblastosis.  
Methylmalonyl-CoA mutase may serve mainly to remove toxic products of lipid 
breakdown (133). The mutase or B12 deficiency results in an often fatal methylmalonic 
acidemia (133), and in certain neuropsychiatric symptoms. These symptoms may result 
from synthesis of abnormal myelin lipids in the presence of accumulated methylmalonic 
acid (MMA) (3, 175), a myelin (a dielectric material that forms myelin sheath around the 
axon of a neuron) destabilizer. Excessive MMA will prevent normal fatty acid synthesis, 
or it will be incorporated into fatty acid itself rather than normal malonic acid. If this 
abnormal fatty acid subsequently is incorporated into myelin, the resulting myelin will be 
too fragile, and demyelination will occur. Although the precise mechanism(s) are not 
known with certainty, the result is subacute combined degeneration of central nervous 
system and spinal cord (157). 
Thus, disorders of cobalamin transport and metabolism (Fig. 1.15), whether inherited 
or acquired, manifest themselves as deficiencies in the activities of one or both of these 
enzymes and lead to accumulation in blood and urine of one or both of the substrates, 
homocysteine and methylmalonyl-CoA, respectively.  
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FIG. 1.15. Schematic view of the intracellular B12 trafficking pathway (17). The known and proposed 
functions of the gene products associated with the complementation groups cblA-G and mut are 
indicated. The question marks highlight some aspects of the trafficking pathway that are poorly 
characterized. 
Clinical studies on patients with inborn errors of cobalamin metabolism identified eight 
genetic complementation groups that underlie this disease, cblA-G and mut (87, 241), and 
provided early insights into a complex pathway for intracellular processing of B12. From 
such studies, these cobalamin disorders can be divided to three subclasses: those resulting 
(i) in combined defects in both the MeCbl and AdoCbl branches (cblF, cblC, and cblD), 
(ii) in an isolated defect in MeCbl branch (cblG and cblE), and (iii) in an isolated defect 
in AdoCbl branch (cblA, cblB, and mut). To date, all eight genes responsible for the 
defects in intracellular cobalamin metabolism have been identified but some of their 
functions await elucidation: the gene LMBRD1 (cblF locus) encodes a B12 transporter; 
MMACHC (cblC) encodes a decynase and dealkylase; MMADHC (cblD) probably codes 
for a transpoter or an adaptor protein; the cblG locus encodes methionine synthase; cblE 
encodes methionine synthase reductase; cblA encodes MMAA with functions of editing, 
gating and radical protection; cblB codes for adenosyltransferase and mut encodes 
methylmalonyl-CoA mutase (17). 
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1.2. Nicotinamide adenine dinucleotide (NAD+) 
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a coenzyme found in all 
living cells and also acts as substrate for some enzymes. NAD+ has been central to many 
of the greatest discoveries in the biological sciences.  
1.2.1. Discovery and structure of NAD+ 
In the early 20th century, Arthur Harden and William Youndin reconstituted cell-free 
glucose fermentation with two fractions, one termed ‘zymase’ that was heat-labile and 
retained by dialysis, and one termed ‘cozymase’ that was heat-stable and passed through 
dialysis (92). Zymase was not a purified enzyme but a protein fraction that contained 
glycolytic enzymes. The cozymase fraction contained ATP, Mg2+ and the NAD+ 
coenzyme. Years later, Hans von Euler and Otto Warburg independently determined the 
chemical structure of NAD+ (198, 236). The compound is a dinucleotide, since it consists 
of two nucleotides joined through their phosphate groups, with one nucleotide containing 
an adenine base and the other containing nicotinamide (Fig. 1.16). 
        
FIG. 1.16. The structure of Nicotinamide adenine dinucleotide (NAD+). A, Structural formula of NAD+; 
B, Stick model of NAD+. 
1.2.2. Biosynthesis of NAD+ 
According to a widely accepted concept, a combination of de novo pathway from 
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amino acids and salvage pathways by recycling preformed components contributes to the 
biosynthesis of NAD+ (166, 187). Some NAD+ is also converted into nicotinamide 
adenine dinucleotide phosphate (NADP+) that has the chemistry similar to that of NAD+ 
but different roles in metabolism. 
 
FIG. 1.17. NAD+ biosynthesis (de novo and salvage) pathways (adapted from references (34, 115)). 
Two de novo pathways, the aspartate pathway and kynurenine pathway, converge at quinolinic acid, 
and subsequently use three common steps to synthesize NAD+. In salvage metabolic pathways, three 
natural nicotinamide-ring contained compounds, nicotinic acid (Na), nicotinamide (Nam), and 
nicotinamide riboside (NR), and possibly nicotinic acid riboside (NaR), are recycled back to the 
NAD+. 
1.2.2.1. De novo production 
Most organisms synthesize NAD+ from simple building-blocks from the amino acids 
tryptophan or aspartic acid (23). The specific set of reactions differs among organisms, 
but a common feature is the generation of quinolinic acid from an amino acid - either 
tryptophan (Trp) (kynurenine pathway) in animals and some bacteria, or aspartic acid 
(Asp) (aspartate pathway) in some bacteria and plants (21, 83, 116, 137) (Fig. 1.17). The 
quinolinic acid is converted to nicotinic acid mononucleotide (NaMN) by transfer of a 
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phosphoribose moiety. An adenylate moiety is then transferred to form nicotinic acid 
adenine dinucleotide (NaAD). Finally, the nicotinic acid moiety in NaAD is amidated to a 
nicotinamide moiety, forming nicotinamide adenine dinucleotide (23, 34, 115). 
1.2.2.2. Salvage pathways 
In an alternative fashion, more complex components of the coenzymes are taken up 
from food as the vitamin called niacin (B3) which is a mixture of nicotinic acid and 
nicotinamide. Similar compounds such as nicotinic acid (Na), nicotinamide (Nam), and 
nicotinamide riboside (NR) are released by reactions that break down the structure of 
NAD+. These precursors are fed into the NAD+ biosynthetic pathway, shown in Figure 
1.17, through adenylation and phosphoribosylation reactions that recycle them back into 
the active form (34, 115, 146).  
Salvage pathway is essential, especially for some microorganisms such as yeast 
Candida glabrata and the bacterium Haemophilus influenzae which are NAD+ 
auxotrophs - they cannot synthesize NAD+ de novo - but possess salvage pathways and 
thus are dependent on external sources of NAD+ or its precursors (141, 179). 
1.2.3. Function of NAD+ 
NAD+ has several essential roles in all living systems. For several decades, it has been 
known that NAD+ acts as a coenzyme in redox reactions. In recent years, multiple 
enzyme-mediated, nonredox roles for NAD+ have been discovered, such as acting as a 
donor of ADP-ribose moieties in ADP-ribosylation reactions, as a precursor of the second 
messenger molecule cyclic ADP-ribose, as well as acting as a substrate for a group of 
enzymes called sirtuins that use NAD+ to remove acetyl groups from proteins and as a 
dehydrating agent for bacterial DNA ligases. 
1.2.3.1. Oxidation-reduction reactions 
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NAD+ is classically known to play a major role as a coenzyme in numerous metabolic 
reactions. The main function of NAD+ in metabolism is to act as an electron carrier to 
transfer electrons from one molecule to another, involved in redox reactions. Such 
reactions (RH2 + NAD+ → NADH + H+ + R) involve the removal of two hydrogen atoms 
from the reactant RH2, in the form of a hydride ion (H−), and a proton (H+). The proton is 
released into solution, while the reductant RH2 is oxidized and NAD+ was reduced to 
NADH by transfer of the hydride to the nicotinamide ring. NADH can then be used as a 
reducing agent to donate electrons and be re-oxidized to NAD+ (Fig. 1.18). This means 
the coenzyme can continuously cycle between the NAD+ and NADH forms without being 
consumed (170). These electron transfer reactions are the main function of NAD+ and are 
catalyzed by a large group of enzymes called oxidoreductases.  
 
FIG. 1.18. NAD+ as a coenzyme for reversible hydride transfer (23). 
The redox reactions are vital in all parts of metabolism, but one particularly important 
area where these reactions occur is in the release of energy from nutrients. Here, reduced 
compounds such as glucose are oxidized, thereby releasing energy. This energy is 
transferred to NAD+ by reduction to NADH, as part of glycolysis and the citric acid cycle, 
and then to respiratory chain where the energy eventually is released through oxidative 
phosphorylation. 
1.2.3.2 Regulatory reactions 
NAD+ serves as a substrate for covalent modifications of target molecules and is also 
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involves in signal transduction as precursors of messenger molecules (249). All known 
derivatives share structural similarity owing to their ADP-ribose backbone (Fig. 1.19). 
Thus, NAD+-mediated signalling reactions can be referred to as ADP-ribosyl transfers, 
because the initial cleavage of NAM (leaving the ADP-ribosyl moiety) is common to all 
of them. The eventual acceptors of the transfer reaction are rather diverse, including 
macromolecules such as proteins, or small molecules such as water (yielding ADP-ribose), 
acetate [yielding OAADPr (O-acetyl ADP-ribose)] or the adenine ring leading to 
intramolecular cyclization into cADPr (cyclic ADP-ribose; Fig. 1.19) (170). 
 
FIG. 1.19. Signalling derivatives of NAD+ (170).  
ADP-ribosylations are catalyzed by mono-ADP-ribosyltransferases (ARTs) and 
poly(ADP-ribose polymerases (PARPs), which involves either the addition of a single 
ADP-ribose moiety or the transferral of ADP-ribose to aceptors in long branched chains, 
respectively (170). Mono-ADP-ribosylation was originally identified as the mechanism of 
a group of bacterial toxins, notably cholera toxin, but it is also involved in normal cell 
signaling (24, 58, 231). The poly(ADP-ribose) structure is involved in the regulation of 
several cellular events and is most important in the cell nucleus, in processes such as 
DNA repair and telomere maintenance (45). 
NAD+ is also the precursor of cyclic ADP-ribose, which is produced from NAD+ by 
ADP-ribosyl cyclases (or cADP-ribose synthases), as part of a second messenger system 
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(88). This molecule acts in calcium signaling by releasing calcium from intracellular 
stores (89). It does this by binding to and opening a class of calcium channels called 
ryanodine receptors, which are located in the membranes of organelles, such as the 
endoplasmic reticulum (90). 
Sirtuins such as silent information regulator 2 (Sir2) are another class of 
NAD+-consuming enzymes, which transfer an acetyl group from their substrate protein to 
the ADP-ribose moiety of NAD+; this cleaves the coenzyme and releases nicotinamide 
and O-acetyl-ADP-ribose. The sirtuins mainly seem to be involved in regulating 
transcription through deacetylating histones and altering nucleosome structure (27, 107). 
1.2.3.3. DNA ligation 
Other NAD+-dependent enzymes include bacterial DNA ligases, which join two DNA 
ends by using NAD+ as a substrate to donate an adenosine monophosphate (AMP) moiety 
to the 5' phosphate of one DNA end. This intermediate is then attacked by the 3' hydroxyl 
group of the other DNA end, forming a new phosphodiester bond (83, 134, 240). This 
contrasts with all DNA ligases identified within archaea, viruses and eukarya, which use 
ATP to form DNA-AMP intermediate (134, 213, 227, 240). 
1.2.4. NAD+-related diseases 
Due to its ubiquitous coenzyme roles and specific signaling functions, NAD+ is 
indispensible in cellular metabolism and regulation. A lack of NAD+ or its precursors 
such as niacin and tryptophan in the diet causes the vitamin deficiency disease pellagra 
(100). This high requirement for NAD+ results from the constant consumption of the 
molecule in reactions like histone modifications, DNA repair, and telomere maintenance 
in cell nucleus (23, 45), accounting for that the enzymes involved in the salvage pathways 
appear to be concentrated in this organelle (6).
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1.3. AdoCbl-dependent 1,2-propanediol (1,2-PD) degradation 
1.3.1. Source of 1,2-PD 
  1,2-PD is a major product of the fermentation of the sugars L-fucose and L-rhamnose 
(2, 10, 12, 35, 36, 138) (Fig. 1. 20). These two methyl pentoses are metabolized in E. coli 
and S. enterica through inducible pathways that show a striking parallelism. Both 
pathways are sequentially mediated by a permease, an isomerase, a kinase, and an 
aldolase (2, 36). The stereochemical difference between the configurations of both sugars 
at carbon 2 and carbon 4 disappears with cleavage of the fuculose-1-phosphate or 
rhamnulose-1-phosphate by the corresponding aldolases, yielding in each case 
dihydroxyacetone phosphate (DHAP) and L-lactaldehyde. The two homologous sets of 
inducible proteins are specific for the metabolism of their corresponding sugars and are 
coded for by two different gene clusters.  
    
FIG. 1.20. Pathway of L-fucose and L-rhamnose dissimilation (adapted from ref. (12, 36)). 
L-lactaldehyde is a branching point in the metabolic pathway of L-fucose and 
L-rhamnose utilization. Further metabolism of L-lactaldehyde follows two different 
pathways, depending on the availability of oxygen. Under aerobic conditions, the 
aldehyde is oxidized to L-lactate in an irreversible reaction catalyzed by the 
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NAD+-dependent lactaldehyde dehydrogenase and L-lactate is further oxidized to 
pyruvate by a dehydrogenase of the flavoprotein class to enter central metabolism. 
Whereas under anaerobic conditions, L-lactaldehyde is reduced to L-1,2-propanediol by 
the enzyme propanediol oxidoreductase in a typical fermentative mechanism in which 
NADH is oxidized to NAD+ (12, 35, 36). 
1.3.2. 1,2-PD utilization 
In E. coli, 1,2-PD is excreted to the environment as a fermentation product (55). In 
contrast, a number of enteric and lactic acid bacteria such as S. enterica (163) further 
utilize 1,2-PD in a coenzyme B12-dependent fashion.  
 
FIG. 1.21. Anaerobic metabolism of 1,2-PD.  
The first step in this degradative pathway is the AdoB12-dependent diol dehydratase, 
which produces propionaldehyde (Fig. 1.21). This aldehyde can be oxidized to form 
propionyl-CoA by propionaldehyde dehydrogenase or alternatively can be reduced to 
form propanol by propanol dehydrogenase. Through forming and excreting propanol, 
cells can balance internal redox reactions. Under anaerobic conditions, propionyl-CoA 
can be converted by a phosphotransacylase to propionyl-phosphate, and then by a 
reversible acetyl-/propionyl-kinase to propionate, producing one molecule of ATP. 
According to this scheme, anaerobic metabolism of 1,2-PD could provide an electron sink 
(propanol) and a source of ATP but no source of carbon since both propanol and 
propionate are excreted (188). 
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Under aerobic conditions, S. enterica can use propionyl-CoA as both a carbon and an 
energy source through a methycitrate pathway (105) (Fig. 1.22). 
 
 
 
 
 
 
 
FIG. 1.22. Pathway for propionate catabolism in S. enterica (105). PrpE, propionyl-CoA synthetase; 
PrpC, 2-methylcitrate synthase; PrpD, 2-methylcitrate dehydratase; PrpB, 2-methylisocitrate lyase; Pps, 
PEP synthetase; Ppc, PEP carboxylase. 
1,2-PD is a major product of the anaerobic degradation of L-rhamnose and L-fucose 
and is thought to be an important carbon and energy source in natural environments (138). 
These two sugars are common in plant cell walls, bacterial capsules (exopolysaccharides) 
and the glycoconjugates of eukaryotic (intestinal epithelial) cells. So the ability to 
degrade 1,2-PD is thought to provide a selective advantage in anaerobic environments 
such as the large intestines of higher animals, sediments and the depths of soils. The 
utilization ability is found in a number of bacterial genera including Salmonella, Shigella, 
Lactococcus, Lactobacillus, Yersinia, Listeria, and Klebsiella (53). 
1.3.3. The pdu locus in S. enterica 
S. enterica degrades 1,2-PD via a coenzyme B12-dependent pathway (110). 
Twenty-four genes specifically involved in 1,2-PD utilization (pdu) are found in a single 
contiguous cluster, the pdu locus (31, 110) (Fig. 1.23). This locus consists of the pocR and 
pduF genes as well as the adjacent, but divergently transcribed pdu operon which 
includes 22 pdu genes (pduABB'CDEGHJKLMNOPQSTUVWX, pduB and pduB’ arise 
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from alternate start sites.). The pdu locus encodes a transcriptional regulator (30, 184), a 
diffusion facilitator (51), enzymes for the degradation of 1,2-PD (31, 32, 129, 139) and 
cobalamin metabolism (31, 74, 113, 156, 194), as well as proteins for the formation of a 
bacterial microcompartment (MCP) used for 1,2-PD utilization (31, 94, 95, 193). These 
genes for 1,2-PD utilization (pdu) were acquired together with 20 genes for AdoCbl 
biosynthesis by a single horizontal gene transfer event that is thought to be one of several 
related events important to the divergence of S. enterica and E. coli (31, 128, 189). 
 
 
FIG. 1.23. The pdu locus of S. enterica.  
Based on experimental evidence and/or sequence similarity the proteins encoded by the 
pdu locus can be categorized into six groups: PocR, transcriptional regulator (30, 184); 
PduF, 1,2-PD diffusion facilitator (51); PduA, PduB, PduB’, PduJ, PduK, PduN, PduT, 
and PduU, MCP shell proteins (31, 62, 95); PduCDE, PduL, PduP, PduQ, PduW, 1,2-PD 
degradative enzymes (diol dehydratase, phosphotransacylase, propionaldehyde 
dehydrogenase, propanol dehydrogenase, and propionate kinase, correspondingly) (31, 32, 
129, 139, 164); PduGH, PduO, PduS, and PduX, cobalamin synthesis and recycling (diol 
dehydratase reactivase, adenosyltransferase, cobalamin reductase, and L-threonine kinase, 
correspondingly) (31, 52, 74, 113, 156, 194); and PduM and PduV, unknown function - 
possibly an MCP shell protein and a GTPase (53). 
1.3.4. Control of the pdu/cob regulon 
The pdu operon maps adjacent to the cob operon which encodes B12 synthetic enzymes 
in S. enterica. The two operons are both induced by 1,2-PD using a single regulatory 
protein. Two global regulatory systems (Crp/Cya and ArcA/ArcB) affect inducibility of 
the cob and pdu operons (1, 7, 72). Both operons are activated aerobically and 
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anaerobically by Crp protein and anaerobically by ArcA protein. The control of the 
regulon depends on five promoters, all located in the central region between the cob and 
pdu operons; four of these promoters are activated by the PocR protein (50). 
 
 
 
 
 
 
FIG. 1.24. Regulation of the cob/pdu regulon of S. enterica (188). Boxes enclose structural genes. 
Black arrows designate transcripts. Gray arrows indicate regulatory influence; dashed gray arrows 
indicate the proposal that a higher level of PocR protein may be required to activate these promoters. 
The current model for control of this system includes the following features (Fig. 1.24): 
The cob and pdu operons are transcribed divergently from promoters indicated at the far 
right and left in the figure. These promoters are activated whenever both the PocR protein 
and 1,2-PD are present. Global control of the two operons is exerted by varying the level 
of PocR protein. The pocR gene is transcribed by three promoters controlled both by 
global regulatory proteins and by autoinduction (50). The shortest transcript (from Ppoc) 
appears to be regulated only by Crp/cAMP. The P2 transcript clearly is autoregulated by 
PocR and, in addition, requires the ArcA protein, which signals a reduced cell interior 
(50). Control of the P1 promoter is less certain but may involve either the Fnr protein 
(responding to a reduced cell interior) or the Crp protein (responding to a shortage of 
carbon and energy) in addition to the PocR activator. The involvement of these proteins in 
control of P1 is based heavily on the presence of appropriate binding sites upstream of 
that promoter.  
It is proposed that the regulon has three states (188). In the off condition (during 
aerobic growth on glucose), all promoters are at their lowest level; PocR protein is 
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produced by the basal expression levels of promoters P1, P2, and Ppoc. Cells enter a 
standby state when they grow under any set of global conditions appropriate for induction, 
but without 1,2-PD. These conditions include aerobic growth on a poor carbon source 
and/or growth without oxygen. These conditions stimulate expression of both the PduF 
transporter and the PocR regulatory protein, but the cob and pdu operons remain 
uninduced. The standby expression of PocR can occur from the Ppoc and/or the P1 
promoter without inducer. The two proteins induced in the standby state (PduF and PocR) 
are those needed to sense 1,2-PD. If 1,2-PD appears, the P1 and P2 promoters are induced, 
increasing the level of PocR protein and placing the system in the on state. The resulting 
high level of PocR/1,2-PD complex induces expression of the cob and pdu promoters. 
These results indicate that 1,2-PD catabolism is the primary reason for de novo B12 
synthesis in S. enterica (30, 189). If one includes the cob genes, S. enterica maintains 
nearly 50 genes primarily for the degradation of 1,2-PD. Virtually all natural Salmonella 
isolates tested synthesize AdoCbl de novo and degrade 1,2-PD (128). 
1.3.5. Pathogenesis 
The capacity for 1,2-PD degradation is found among a number of genera that inhabit 
the large intestines of higher animal including some pathogens. Studies conducted with 
two intracellular human pathogens, Salmonella and Listeria, have implicated 1,2-PD 
degradation in pathogenesis. In Salmonella, pdu genes are induced in host tissues and 
co-regulated with invasion genes by CsrA (57, 126). In addition, pdu mutants are 
impaired for growth in macrophages and show a virulence defect in competitive index 
assays with mice (98, 121). In Listeria, comparative genomics indicates a link between 
1,2-PD degradation and pathogenesis, and several pdu genes are induced during 
intracellular growth in host cells (43, 114). 
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1.4. Bacterial microcompartment 
Many bacteria conditionally express protein-based organelles referred to here as 
microcompartments (MCPs). These MCPs are thought to be involved in at least seven 
different metabolic processes ranging from CO2 fixation to the degradation of small 
organic molecules, and the number is growing (53). MCPs are very large and structurally 
sophisticated. They are usually about 100-150 nm in cross-section and consist of 
10,000-20,000 polypeptides of 10-20 types. Their unifying feature is a solid shell 
constructed from proteins having bacterial microcompartment (BMC) domains that are 
widely distributed across the bacterial kingdom. Encased within the shell are 
sequentially-acting metabolic enzymes. MCPs are made completely of protein subunits 
(49, 94, 104). There are no confirmed reports of RNA, DNA, or lipids functionally 
associated with the MCPs that have been investigated. In the cases that have been studied, 
the metabolic sequences associated with MCPs have toxic or volatile intermediates. It is 
thought that the shell of the MCP confines such intermediates, thereby enhancing 
metabolic efficiency and/or protecting cytoplasmic components. 
1.4.1. Discovery and diversity 
Carboxysomes were the first bacterial MCPs to be discovered (Fig. 1.25 A, B). They 
were observed more than 50 years ago as inclusion bodies with a polygonal appearance in 
the cytoplasm of cyanobacteria Phormidium uncinatum (68). Initially, carboxysomes were 
mistaken for viruses because of their resemblance to phage particles. Over the next 20 
years, these inclusions, which were named polyhedral bodies in 1961 (109), were found 
in various other cyanobacteria  (for example, Nostoc punctiforme, Synechococcus 
elongatus, Anabaena cylindrica and Symploca muscorum) and chemoautotrophs (for 
example, Halothiobacillus neapolitanus, Acidithiobacillus ferrooxidans, Nitrobacter 
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winogradskyi and Nitrococcus mobilis) (53, 209, 245). Polyhedral bodies were first 
isolated in 1973 from the chemoautotrophic bacterium H. neapolitanus by differential and 
sucrose step-gradient centrifugation, following rupture in a French pressure cell (210). 
These bodies were surrounded by a proteinaceous envelope (the shell) and contained the 
enzymes ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) and carbonic 
anhydrase (CA) involved in CO2 fixation; to reflect this finding, the name carboxysome 
was proposed (85, 210). It is now widely accepted that although carboxysomes are 
probably found in all cyanobacteria, they are present in only a limited number of 
chemoautotrophs: namely, some of the sulphur and nitrifying bacteria (for example, 
species of Thiobacillus, Halothiobacillus, Thiomonas, Acidithiobacillus, Nitrobacter and 
Nitrosomonas) (48, 96, 245).  
D A C
 
 
 
FIG. 1.25. Electron micrographs of MCPs (100-150 nm in cross section) A. The carboxysomes (α-type) 
in H. neapolitanus; B. The purified carboxysomes (α-type) from H. neapolitanus. C. The Pdu MCPs in 
S. enterica grown on 1,2-PD; D. The purified Pdu MCPs from S. enterica. 
A variety of studies indicate two main classes of carboxysomes, α and β, which vary 
slightly in composition. Each class is thought to have co-evolved with a different 
phylogenetic group of RuBisCO (8, 9). The α-carboxysome is associated with form 1A 
RuBisCO which is found in chemoautotrophs and α-cyanobacteria while the 
β-carboxysome is associated with form 1B RuBisCO which is found in the 
β-cyanobacteria (9). Overall, α- and β-carboxysomes are thought to have similar 
architectural and mechanistic principles. 
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For many years, carboxysomes were the only known bacterial MCPs. Then, in 1994, 
genetic studies and sequence analyses indicated that the PduA protein (encoded by the 
pdu locus that is involved in B12-dependent 1,2-PD degradation by S. enterica) exhibited 
relatively high sequence identity to carboxysome shell protein CcmK (51). A few years 
later, electron microscopy showed that S. enterica conditionally formed MCPs during 
B12-dependent growth on 1,2-PD (211) (Fig. 1.25 C, D). Further work indicated that 
seven more Pdu proteins (PduB/B’/J/K/N/T/U) are related to the shell proteins involved 
in the formation of carboxysomes (31), providing additional evidence for Pdu MCP 
formation. A simultaneous study on B12-dependent ethanolamine utilization (eut) by S. 
enterica indicated that five eut genes (eutK/L/M/N/S) encode homologues of the shell 
proteins of the carboxysomes and the Eut MCPs were observed by electron microscopy as 
well (40, 122). 
Genomic analyses indicated that bacterial MCPs are widespread and functionally 
diverse. Approximately 20-25% of bacteria encode homologues of BMC-domain proteins, 
although none has been detected in the archaea or eukarya (29). Multiple genes for 
BMC-domain proteins are often found in gene clusters that also encode MCP-associated 
enzymes or putative enzymes. Variation in such gene clusters suggests bacterial MCPs 
have diverse functions. Established MCPs include carboxysomes and the Pdu and Eut 
MCPs. Several putative MCPs are inferred from gene clustering analyses: 1. A MCP 
associated with a pyruvate-formate lyase homolog is proposed to be involved in the 
production of ethanol from pyruvate (234); 2. A MCP was suggested to be involved in the 
oxidation of ethanol by Clostridium kluyveri (208); 3. A putative MCP in Rhodopirellula 
baltica SH 1 is associated with a lactate dehydrogenase homologue; 4. A putative MCP in 
Carboxydothermus hydrogenoformans Z-2901 is associated with an 
isochorismatase-family protein; 5. A putative MCP Solibacter usitatus Ellin6076 
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associated with a dihydrodipicolinate synthase homologue, and the list is expected to 
grow as more genome sequences become available (29). Certainly, this diversity is one of 
the most intriguing aspects of bacterial MCPs. It raises important questions about their 
functional principles, the extent to which those principles are conserved, and the degree to 
which they can be adapted and modified (or engineered) to fulfill the needs of a particular 
metabolic system (53).  
1.4.2. Component and architecture 
For many years there was uncertainty about the overall shape of carboxysomes. Recent 
electron cryotomography of carboxysomes from H. neapolitanus (α-type) and 
Synechococcus strain WH8102 (β-type) indicate an icosahedral or quasi-icosahedral 
structure (106, 200) (Fig. 1.25 B). The shape of Pdu MCPs is also roughly polyhedral, but 
they are more irregular than carboxysomes (Fig. 1.25 D). Eut MCPs have not been 
purified (117, 244), but the unisolated Eut MCPs in Salmonella cells look like 
carboxysomes and Pdu MCPs under the electron microscope (40).  
In the lumen of the MCPs, there are several enzymes presumed to carry out required 
metabolic functions. For example, the carboxysomes consist mainly of RuBisCO and CA 
involved in CO2 fixation (85, 210), while the Pdu MCPs contain PduCDE, PduGH, PduO, 
and PduP, functioning in 1,2-PD degradation (94, 129). 
Gene sequencing and MCP purification experiments demonstrated that MCPs are 
composed of a few protein components in addition to those enzymes (49, 94, 104, 173). 
The most abundant nonenzymatic components purified from both carboxysomes and Pdu 
MCPs are members of a conserved family of small proteins, typically around 100 (single) 
or 200 (tandem) amino acids in length, that define the BMC protein domain (InterPro 
domain IPR000249, Pfam 00936). These BMC proteins are the major constituents of 
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MCP shells. Furthermore, in all organisms for which genomic data have revealed a BMC 
protein for a presumptive MCP, multiple paralogous BMC proteins have been found. For 
example, CsoS1A/B/C/D are present in α-type carboxysome, CcmK/O in β-type, 
PduA/B/B’/J/K/T/U for Pdu, and EutL/M/K/S for Eut. The involvement of multiple 
distinct BMC proteins in the shell appears to be a strongly conserved feature (20, 118).  
  To date, crystal structures of 13 different BMC proteins have been determined, some in 
multiple crystal forms and conformations. These include three (CsoS1A/C/D) from the 
α-type carboxysome (120, 229, 230), two (CcmK2/4) from the β-type (118), three 
(PduA/T/U) from the Pdu MCP (60, 62), four (EutK/L/M/S) from the Eut MCP (191, 
224), and one (EtuB) predicted to function in an ethanol-utilizing (Etu) MCP (99). From 
these crystal structures, basic features of assembly and transport have been inferred. 
The BMC domain adopts an α/β-fold with a central four-stranded antiparallel sheet 
flanked by small helices. Single BMC-domain proteins usually form flat hexamers with 
cyclic (C6) symmetry, or some variation on that arrangement, while the shell proteins 
with two tandem BMC domains form hexagonal trimers (pseudohexamers) (117) (Fig. 
1.26). Numerous lines of evidence therefore show that hexamers and pseudohexamers 
comprise the building blocks of bacterial MCP shells (118, 229, 247). Most BMC shell 
proteins adopt structures in which the hexamer has a prominent bowl-shaped depression 
on one side, specifically the side on which both the N and C termini reside in the typical 
BMC domain (244).  
Several different crystal structures of BMC proteins reveal tightly packed 
two-dimensional layers of molecules (118, 191, 229, 230) (Fig. 1.26). The shape of the 
BMC hexamers and pseudohexamers are evidently tailored for further side-by-side 
assembly into a mixed molecular sheet, roughly 20 Å thick on average, with a 
center-to-center distance between hexamers/pseudohexamers ranging from 66 to 69 Å, 
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suggesting that MCP shells are a mosaic of different types of BMC-domain proteins. The 
molecular layer is nearly solid, except for narrow pores through the centers of the 
hexamers/pseudohexamers and where hexamers/pseudohexamers meet at twofold and 
threefold axes of symmetry. Another BMC protein (EutS) is a bent hexamer that could 
form the edges of the shell (224). The presence of BMC shell proteins effectively defines 
the bacterial MCP family of organelles (244). 
 
FIG. 1.26. The elements of the architecture of the carboxysome shell, modeled as an icosahedron 
assembled from hexamers (single BMC domain proteins, blue), pseudohexamers (tandem BMC 
domain proteins, green, gold, and pink), and pentamers (quaternary structure of Pf03319 domain in 
CcmL, yellow) (117). 
In addition to the major (BMC-type) shell proteins, the presence of one minor protein 
is also conserved across MCPs and is named according to MCP type: CsoS4A/B 
(α-carboxysome), CcmL (β-carboxysome), PduN, or EutN - collectively referred to as the 
CcmL/EutN protein family (Pfam 03319). Proteins from the CcmL/EutN family are found 
encoded in operons wherever BMC genes are present (244). However, the homologous 
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gene products in the α-carboxysome operon (CsoS4A/B) were not detected initially in 
purified H. neapolitanus carboxysomes (49), but the deletion of the ccmL gene in 
cyanobacterial β-carboxysomes gave rise to aberrant, elongated tubular carboxysomes 
(173). Crystal structures of corresponding proteins, CsoS4A and CcmL, from the two 
types of carboxysomes clarified their structural roles. Both proteins are pentamers whose 
sizes and shapes are compatible with formation of vertices in an icosahedral shell 
assembled mainly from BMC hexamers (222). On that basis, rough atomic models of 
carboxysome shells have been constructed (Fig. 1.26). Models in which the CcmL or 
CsoS4 proteins occupy icosahedral vertices explain the two key observations noted above. 
First, vertex proteins would be present in only 60 copies per shell, compared to a few 
thousand for the BMC proteins and the RuBisCO subunits, explaining difficulties in 
detection; later studies confirmed the expression of the csoS4A/B genes (47). Second, in 
the absence of pentagonal vertices, a flat layer of hexamers can roll up into a tube, 
whereas introducing the (Gaussian) curvature required to close the ends is problematic 
without pentamers (244). 
  In different MCPs, multiple proteins are present that are apparently neither enzymatic 
nor homologous to the major BMC or the minor CcmL/EutN shell protein family. Such 
proteins are presumed either to help organize the MCP enzymes, or to be minor structural 
components of the shell. There is considerable variation regarding the accessory proteins 
present in different MCPs (244).  
  Like the lipid bilayer of membrane bound-organelles, the bacterial MCP shell has 
conduits through which metabolites selectively pass. The canonical BMC proteins whose 
structures have been determined typically have pores with diameters ranging from 4 to 6 
Å (118, 229, 247). These pores are likely large enough to permit the diffusion of small 
substrates and products of the known MCPs (e.g., bicarbonate (HCO3−), 3-PGA, 
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1,5-RuBP, ethanolamine, and 1,2-PD). Positive electrostatic potential has been noted in 
the hexameric pores of the major BMC proteins of the carboxysome (223, 229). It has 
been suggested that this could confer a kinetic advantage for HCO3− diffusion into the 
shell. CO2 and O2, whose respective outward and inward passages are undesirable, would 
not benefit from the same electrostatic advantage as HCO3− (244). 
  A recent study showed the structure of a newly identified carboxysome shell protein, 
CsoS1D, existing in two dramatically different conformations (120). The two 
conformations of CsoS1D correspond to an open and closed central pore. The closed form 
is essentially occluded, whereas the open form has a pore roughly 14 Å in diameter. 
Likewise, EutL has been visualized in two different conformations, one that is nearly 
occluded (191, 224) and one that has a roughly 11 Å pore (224). In addition to offering an 
explanation of how larger molecules might be transported, the two conformations suggest 
a potential gating mechanism that could control which molecules pass through the shell 
(120, 224). This would help address the question of how larger molecules might be able 
to pass through a shell that presents a diffusion barrier to smaller compounds (244). 
  A second potentially significant observation is that CsoS1D tends to form a double-disk 
structure via a face-to-face interaction of two trimers (or pseudo- hexamers). This creates 
a large interior cavity. In two different crystal forms, the double-disk is composed of one 
trimer in the open configuration and a second in the closed configuration, leading the 
investigators to suggest an alternating access mechanism (120). The discovery of dynamic 
shell proteins (CsoS1D and EutL) hints that further studies on diverse MCP proteins will 
reveal a multitude of varied pores and transport mechanisms (244). 
1.4.3. Function and mechanism 
Data have been presented for the existence of bacterial MCPs carrying out at least 
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seven different metabolic pathways. Three of these pathways have been explored 
experimentally (carboxysomes, Pdu and Eut MCPs).  
  Carboxysome is thought to work in conjunction with C1 transport systems as part of a 
bacterial CO2 concentrating mechanism (CCM) thereby enhancing carbon fixation and 
autotrophic growth (53, 172, 244). It is now generally understood that CA is colocalized 
with RuBisCO inside the carboxysome (59, 97, 171) and that this is a key mechanistic 
feature for enhancing CO2 fixation when the concentration of inorganic carbon is low, as 
it is in most natural environments. The carboxysome comprises the second part of the 
CCM, whose first part is the concentration of HCO3− inside the cell by active transport 
across the cytoplasmic membrane and into the cytosol (9). Current models hold that 
HCO3− then crosses the protein shell and enters the carboxysome by diffusion. In the 
lumen of the carboxysome, CA dehydrates HCO3− to CO2 to increase the level of CO2 in 
the local vicinity of RuBisCO, thereby countering the low catalytic efficiency and poor 
substrate selectivity of RuBisCO for CO2 (Fig. 1.27). The carboxysome shell is believed 
to play a role in allowing or limiting the transport of substrates and products [i.e., HCO3−, 
CO2, 3-phosphoglycerate (3-PGA), and ribulose-1,5-bisphosphate (RuBP)] (67, 118, 180, 
196) and possibly O2 (144), which competes with CO2 in its reaction with RuBisCO. 
    
 
FIG. 1.27. CO2 fixation by carboxysomes (adapted from ref. (244)). CA, carbonic anhydrase; RuBP, 
ribulose-1,5-bisphosphate, RuBisCO, ribulose-1,5-bisphosphate carboxylase/oxygenase; 3-PGA, 
3-phosphoglycerate. 
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Pdu and Eut MCPs have a different function than carboxysomes (53, 244) (Fig 1.28). 
They work to mitigate aldehyde toxicity and diffusive loss. A common feature of the 
1,2-PD and ethanolamine degradative pathways is that both proceed through aldehyde 
intermediates (propionaldehyde and acetaldehyde, respectively); hence, it was proposed 
that MCPs might be formed to sequester aldehydes which were known cytotoxins (219). 
Studies showed that mutants unable to form the Pdu MCPs accumulated large amounts of 
propionaldehyde and underwent a temporary period of growth arrest due to 
propionaldehyde toxicity (95, 193). In addition, propionaldehyde was found to be a 
mutagen and mutation frequencies were increased in MCP mutants during growth on 
1,2-PD (193). The aldehyde toxicity model is further supported by the findings that polA 
(DNA repair polymerase) and gsh (glutathione biosynthesis) mutants were unable to grow 
on ethanolamine (185, 186). However, other studies have indicated that the main role of 
the Eut MCP might be to prevent the loss of the volatile metabolic intermediate, 
acetaldehyde (167). In the case of propionaldehyde (boiling point = 48 °C), loss due to 
volatility appears less important than for acetaldehyde (boiling point = 20 °C) (193). 
  
A B 
 
FIG. 1.28. Proposed pathways for 1,2-PD (A) and ethanolamine (B) degradation by Pdu and Eut MCPs, 
respectively (244). PduCDE, B12-dependent diol dehydratase; PduO, adenosyltransferase; PduGH, diol 
dehydratase reactivase; PduP, propionaldehyde dehydrogenase; PduQ, propanol dehydrogenase; PduL, 
phosphotransacylase; EutBC, B12-dependent ethanolamine ammonia lyase; EutE, aldehyde 
dehydrogenase; EutD, phosphotransacetylase; EutG, alcohol dehydrogenase.
 
41 
 
1.5. Research overview 
Salmonella is able to utilize 1,2-PD as a sole carbon and energy source in an 
AdoCbl-dependent fashion involving a bacterial MCP (Pdu MCP). Pdu MCP is composed 
entirely of protein subunits and its function is to confine the toxic intermediate 
propionaldehyde during 1,2-PD degradation. Several sequentially-acting metabolic 
enzymes, including the diol dehydratase PduCDE and the propionaldehyde 
dehydrogenase PduP that respectively use AdoCbl and NAD+ as cofactors, are encased 
within the solid protein shell of the MCP. Recent crystallography studies suggested that 
some shell proteins such as PduA, PduT and PduU, have pores that may mediate the 
transport of enzyme substrates/cofactors across the MCP shell. However, localized 
regeneration of cofactors within the MCP might be advantageous for the activity of the 
metabolic enzymes and the efficiency of 1,2-PD degradation. Thus, this study tests the 
hypothesis that AdoCbl and NAD+ are recycled entirely within the Pdu MCP.  
  The first part of this study investigates the bifunctional cobalamin reductase PduS. This 
protein was over-expressed and characterized including its cofactor requirements and 
kinetic properties. The effect of the pduS deletion on 1,2-PD degradation was examed 
through growth studies. Further SDS-PAGE and Western blot of purified Pdu MCP, and 
MS-MS analysis were carried out to test whether the PduS protein is a component of the 
Pdu MCP. Two-hybrid experments were conducted to detect the interaction between PduS 
and the PduO adenosyltransferase that is located in the Pdu MCP and catalyzes the 
terminal step of AdoCbl synthesis. 
  The second part of this study investigates the 1-pronanol dehydrogenase PduQ. 
Experiments similar to those with PduS were used to characterize PduQ biochemically. 
The His-tag protein affinity pull-down assays were performed to test the interaction of 
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PduQ and the PduP propionaldehyde dehydrogenase which is located in the Pdu MCP and 
converts NAD+ to NADH. 
  In conjunction with prior results, the results reported here demonstrate the recycling 
systems of cobalamin and NAD+ within the Pdu MCP. 
 
1.6. Thesis organization 
This dissertation consists of four chapters. Chapter 1 is an introductory review on 
vitamin B12, NAD+, 1,2-PD degradation, and the bacterial MCP. Chapter 2 and 3 are two 
papers related to the topic of the thesis about cofactor regeneration within the Pdu MCP. 
The first paper has been published in the Journal of Bacteriology and the second one is to 
be submitted to a journal. Chapter 4 is a general concluding chapter, where the results and 
conclusions of the two papers are summarized. Both papers were written by me with the 
editorial guidance and assistance from my major professor, Dr. Thomas A. Bobik. 
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Chapter 2. Characterization of the PduS cobalamin reductase of 
Salmonella and its role in the Pdu microcompartment 
 
 
 
 
 
 
 
 
 
 
This chapter, in part or in full, is a reprint of the material as it appears in the Journal of 
Bacteriology (volume 192, pp. 5071-5080, 2010 by Shouqiang Cheng and Thomas A. 
Bobik).
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2.1. Abstract 
Salmonella enterica degrades 1,2-propanediol (1,2-PD) in a coenzyme B12 
(adenosylcobalamin, AdoCbl) -dependent fashion. Salmonella obtains AdoCbl by 
assimilation of complex precursors such as vitamin B12 and hydroxocobalamin. 
Assimilation of these compounds requires reduction of their central cobalt atom from 
Co+3 to Co+2 to Co+1 followed by adenosylation to AdoCbl. In this work, the His6-tagged 
PduS cobalamin reductase from S. enterica was produced at high levels in Escherichia 
coli, purified and characterized. The anaerobically purified enzyme reduced 
cob(III)alamin to cob(II)alamin at a rate of 42.3 ± 3.2 μmol min-1 mg-1, and it reduced 
cob(II)alamin to cob(I)alamin at a rate of 54.5 ± 4.2 nmol min-1 mg-1 protein. The 
apparent Km values of PduS-His6 were 10.1 ± 0.7 μM for NADH and 67.5 ± 8.2 μM for 
hydroxocobalamin in cob(III)alamin reduction. The apparent Km values for cob(II)alamin 
reduction were 27.5 ± 2.4 μM for NADH and 72.4 ± 9.5 μM for cob(II)alamin. HPLC and 
MS indicated that each monomer of PduS contained one molecule of non-covalently 
bound FMN. Genetic studies showed that a pduS deletion decreased the growth rate of 
Salmonella on 1,2-PD supporting a role in cobalamin reduction in vivo. Further studies 
demonstrated that the PduS protein is a component of the microcompartments used for 
1,2-PD degradation (Pdu MCPs) and that it interacts with the PduO adenosyltransferase 
which catalyzes the terminal step of AdoCbl synthesis. These studies further characterize 
PduS, an unusual MCP-associated cobalamin reductase, and in conjunction with prior 
results, indicate that the Pdu MCP encapsulates a complete cobalamin assimilation 
system. 
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2.2. Introduction 
Coenzyme B12 (Adenosylcobalamin, AdoCbl) is an indispensable cofactor for a variety 
of enzymes that are widely distributed among microorganisms and higher animals (14, 
203). Organisms obtain AdoCbl by de novo synthesis or by assimilation of complex 
precursors such as vitamin B12 (cyanocobalamin, CN-Cbl) and hydroxocobalamin 
(OH-Cbl) which can be enzymatically converted to AdoCbl. De novo synthesis occurs 
only in prokaryotes but the assimilation of complex precursors is more widespread taking 
place in many microorganisms and in higher animals (202). A model for the assimilation 
of CN-Cbl and OH-Cbl to AdoCbl, based on work done in a number of laboratories, is 
shown in Figure 2.1. CN-Cbl is first reductively decyanated to cob(II)alamin (91, 119, 
238). Next, cob(II)alamin is reduced to cob(I)alamin and ATP:cob(I)alamin 
adenosyltransferase (ATR) transfers a 5'-deoxyadenosyl-group from ATP to cob(I)alamin 
to form AdoCbl (39, 42, 111, 113, 131, 215, 221, 248). Studies indicate that prior to 
reduction cob(II)alamin binds the ATR and undergoes a transition to the 4-coordinate 
base-off conformer (148, 165, 214, 216, 218). Transition to the 4-coordinate state raises 
the midpoint potential of the cob(II)alamin/cob(I)alamin couple by about 250 mV, 
facilitating reduction (217). OH-Cbl assimilation occurs by a similar pathway except that 
the first step is reduction of OH-Cbl to cob(II)alamin by cobalamin reductase or by the 
reducing environment of the cell (82, 239). 
The pathway used for the assimilation of OH-Cbl and CN-Cbl is also used for 
intracellular cobalamin recycling. During catalysis the adenosyl-group of AdoCbl is 
periodically lost due to by-reactions and is usually replaced by a hydroxo-group resulting 
in the formation of an inactive OH-Cbl-enzyme complex (228). Cobalamin recycling 
begins with a reactivase that converts inactive OH-Cbl-enzyme complex to OH-Cbl and 
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apoenzyme (154, 155). Next, the process described in Figure 2.1 converts OH-Cbl to 
AdoCbl which spontaneously associates with apoenzyme to form active holoenzyme (154, 
155, 228). In the organisms that have been studied, cobalamin recycling is essential, and 
genetic defects in this process block AdoCbl-dependent metabolism (17, 66, 113). 
CN-Cbl 
 OH-Cbl 
cob(II)alamin AdoCb
l
  cob(I)alamin 
cob(III)alamin 
reduction 
reductive 
decyanation 
? 
cob(II)alamin 
reduction 
adenosylation 
PPPi ATP 
breakdown (AdoCbl is unstable in vivo) 
 
FIG. 2.1. Cobalamin assimilation and recycling pathway. Many organisms are able to take up CN-Cbl 
and OH-Cbl and convert them to the active coenzyme form, AdoCbl. This process involves reduction 
of the central cobalt atom of the corrin ring followed by addition of a 5’-deoxyadenosyl (Ado) group 
via a carbon-cobalt bond. The Ado group is unstable in vivo, and AdoCbl breaks down to form OH-Cbl. 
Consequently, cobalamin recycling is required for AdoCbl-dependent processes and recycling uses the 
same pathway that functions in the assimilation of cobalamin from the environment. 
Salmonella enterica degrades 1,2-propanediol (1,2-PD) via an AdoCbl-dependent 
pathway (110). 1,2-PD is a major product of the anaerobic degradation of common plant 
sugars rhamnose and fucose and is thought to be an important carbon and energy source 
in natural environments (138, 163). Twenty-four genes for 1,2-PD utilization (pdu) are 
found in a contiguous cluster (pocR, pduF and pduABB'CDEGHJKLMNOPQSTUVWX) 
(31, 110). This locus encodes enzymes for the degradation of 1,2-PD and cobalamin 
recycling, as well as proteins for the formation of a bacterial microcompartment (MCP) 
(31). Bacterial MCPs are simple proteinaceous organelles used by diverse bacteria to 
optimize metabolic pathways that have toxic or volatile intermediates (29, 48, 53, 246). 
They are polyhedral in shape, 100-150 nm in cross-section (about the size of a large 
virus), and consist of a protein shell that encapsulates sequentially-acting metabolic 
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enzymes. Sequence analyses indicate that MCPs are produced by 20-25% of all bacteria 
and function in seven or more different metabolic processes (53). The function of the Pdu 
MCP is to confine the propionaldehyde formed in the first step of 1,2-PD degradation in 
order to mitigate its toxicity and prevent DNA damage (31, 94, 95, 193). Prior studies 
indicate that 1,2-PD traverses the protein shell and enters the lumen of the Pdu MCP 
where it is converted to propionaldehyde and then to propionyl-CoA by 
AdoCbl-dependent diol dehydratase (PduCDE) and propionaldehyde dehydrogenase 
(PduP) (32, 129). Propionyl-CoA then exits the MCP into the cytoplasm where it is 
converted to 1-propanol, propionate or enters central metabolism via the methylcitrate 
pathway (105, 164). The shell of the Pdu MCP is thought to limit the diffusion of 
propionaldehyde in order to protect cytoplasmic components from toxicity. The Pdu MCP 
was purified and 14 major polypeptide components were identified 
(PduABB'CDEGHJKOPTU) all of which are encoded by the pdu locus (94). 
PduABB'JKTU are confirmed or putative shell proteins (94, 95, 193). PduCDE and PduP 
catalyze the first 2 steps of 1,2-PD degradation as described above (31, 32, 94, 129). The 
PduO and PduGH enzymes are used for cobalamin recycling. PduO is an 
adenosyltransferase (113) and PduGH is a homolog of the Klebsiella diol dehydratase 
(DDH) reactivase which mediates the removal of OH-Cbl from inactive [OH-Cbl-DDH] 
complex (154, 155). However, a reductase which is also required for cobalamin recycling 
was not previously identified as a component of the Pdu MCP (94). This raises the 
question of how cobalamin is recycled for the AdoCbl-dependent DDH that resides within 
the Pdu MCP.  
Prior studies indicated that the PduS enzyme (which is encoded by the pdu locus) is a 
cobalamin reductase (194). Very recently PduS was purified from S. enterica and shown 
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to be a flavoprotein that can mediate the reduction of 4-coordinate cob(II)alamin bound to 
ATR but was not further characterized (147). In this study, PduS from S. enterica is 
purified and more extensively characterized including its cofactor requirements and 
kinetic properties. In addition, we show that PduS is a component of the Pdu MCP. This 
finding in conjunction with prior work indicates that in addition to 1,2-PD degradative 
enzymes the Pdu MCP encapsulates a complete cobalamin recycling system.  
2.3. Materials and methods 
Bacterial strains and growth conditions. The bacterial strains used in this study are 
listed in Table 2.1. The rich media used were Luria-Bertani/Lennox (LB) medium (Difco, 
Detroit, MI) (151) and Terrific Broth (TB) (MP Biomedicals, Solon, OH) (225). The 
minimal medium used was no-carbon-E (NCE) medium (25, 233). 
TABLE 2.1. Bacterial strains used in this study. 
Species and strain Genotype Source 
E. coli 
BE118 BL21(DE3) RIL/pTA925-pduO Lab collection  
C41(DE3) F– ompT hsdSB (rB- mB-) gal dcm (DE3) Lucigen 
BE1355 C41(DE3)/pET-41a This study 
BE1356 C41(DE3)/pET-41a-pduS This study 
BE1374 C41(DE3)/pET-41a-pduS-His6 This study 
BacterioMatch® II 
Two-Hybrid System 
Reporter Strain 
 
Δ(mcrA)183 (mcrCB-hsdSMR-mrr)173 endA1 
hisB supE44 thi-1 recA1 gyrA96 relA1 lac [F´ 
lacIq HIS3 aadA Kanr] 
Stratagene 
S. enterica serovar Typhimurium LT2 
BE1352 ΔpduS::frt This study 
BE287 LT2/pLAC22 Lab collection 
BE1353 ΔpduS::frt /pLAC22 This study 
BE1354 ΔpduS::frt /pLAC22-pduS This study 
 
 
 
Chemicals and reagents. Antibiotics, OH-Cbl, CN-Cbl, AdoCbl, iodoacetate, DNase I, 
FMN, FAD, and corynebacterial sarcosine oxidase were from Sigma Chemical Company 
(St. Louis, MO). IPTG was from Diagnostic Chemicals Limited (Charlotteville PEI, 
Canada). PfuUltra high-fidelity DNA polymerase was from Stratagene (La Jolla, CA). 
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Taq DNA polymerase, restriction enzymes, and T4 DNA ligase were from New England 
Biolabs (Beverly, MA). Other chemicals were from Fisher Scientific (Pittsburgh, PA). 
Construction of plasmids and a pduS-deletion mutant. The pduS gene was amplified 
by PCR (using genomic DNA of S. enterica as the template) then cloned into pET-41a 
vector (Novagen, Cambridge, MA) using NdeI and HindIII restriction sites incorporated 
into the PCR primers as previously described (192). A gene for the production of 
PduS-His6 was similarly cloned with the sequence encoding the His6-tag incorporated 
into the reverse PCR primer. The resulting plasmids pET-41a-pduS, pET-41a-pduS-His6, 
as well as the pET-41a without insert were introduced into Escherichia coli C41(DE3) 
(Lucigen, Middleton, WI). The native pduS gene was also cloned into pLAC22, BglII to 
HindIII, for complementation experiments. The native pduS and pduO genes were cloned 
into both pBT and pTRG (Stratagene) from BamHI to XhoI for two-hybrid analyses. All 
of the above inserts were verified by DNA sequencing.  
The pduS deletion mutant was constructed by a PCR-based method (65) using primers 
(pduS-DKF: CCAATGCCGAAGCCATTCGGGAACTGCTGGAGGAACTGCTATAATT 
GTAGGCTGGAGCTGCTTCG and pduS-DKR: CTAAAATTCCTATAGCCTGAGACA 
TGGTTAACCTCTTACAGATATGAATATCCTCCTTAGTTC). These primers were 
designed to remove nearly the entire pduS coding sequence, but leave predicted 
translation signals of the adjacent genes (pduQ and pduT) intact. The presence of the pduS 
deletion was verified by PCR as described (65).  
Growth of expression strains and purification of PduS-His6. 200 ml TB containing 
25 mg/ml kanamycin was inoculated with 2 ml of BE1374 grown in similar medium and 
the cells were cultivated in a 1 liter baffled Erlenmeyer flask at 37 °C with shaking at 275 
rpm. When the culture reached an OD600 of about 0.5, riboflavin (10 μM), ferric 
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ammonium citrate (50 μg/ml), L-cysteine (1 mM), and IPTG (0.1 mM) were added. The 
culture was incubated for additional 18 h at 30 °C and 200 rpm shaking. Cells were then 
harvested by centrifugation at 4 °C and 6,000 x g for 10 min and used immediately for 
protein purification. Cells were resuspended in buffer A (50 mM potassium phosphate, pH 
7.5, 300 mM NaCl, 5 mM β-mercaptoethanol, 0.4 mM AEBSF [4-(2-aminoethyl) 
benzenesulfonyl fluoride-HCl]) containing 20 mM imidazole and a few crystals of bovine 
pancreas DNase I. Cells were broken using a French pressure cell (SLM Aminco, 
Rochester, NY) at 20,000 psi. Lysates were centrifuged for 30 min at 39,000 x g then 
filtered with a 0.45-μm-pore cellulose-acetate filter. The filtrate (soluble fraction) was 
applied to a pre-equilibrated Ni-NTA column (Qiagen, Valencia, CA). The column was 
washed with 20 bed volumes of buffer A containing 100 mM imidazole and proteins were 
eluted with buffer A containing 300 mM imidazole. Control strains BE1355, BE1356 
were grown in parallel with expression strain BE1374 and similar procedures were used 
for preparing whole-cell extracts and soluble fractions. All protein purification steps were 
carried out at 4 °C either under strictly anaerobic conditions with deaerated buffers inside 
a glove box (Coy Laboratory, Grass Lake, MI) with a nitrogen:hydrogen:CO2 (90:5:5) 
atmosphere, or under aerobic conditions. 
SDS-PAGE and Western blots. Protein concentration was determined using Bio-Rad 
(Hercules, CA) protein assay reagent with bovine serum albumin (BSA) as a standard. 
SDS-PAGE was performed using Bio-Rad 12% or 10-20% gradient Tris-HCl ready gels. 
Protein bands were visualized by staining with Bio-Safe Coomassie Stain (Bio-Rad). For 
Western blots, the proteins on SDS-PAGE gels were transferred to polyvinylidene 
fluoride (PVDF) membranes and probed using SuperSignal West Pico Chemiluminescent 
Substrate (Pierce, Rockford, IL) according to the manufacturer’s instructions with 
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primary mouse anti-PduS sera at the final concentration of 0.5 μg/ml and secondary goat 
anti-mouse IgG-HRP (Santa Cruz Biotechnology, Santa Cruz, CA) at 40 ng/ml. 
Gel filtration. FPLC was carried out using an ÄKTA system (GE Healthcare, 
Piscataway, NJ). Aerobically and anaerobically purified PduS-His6 (0.5 ml at a 
concentration of 20 µM) was applied to a Superdex 200 HR 10/30 column equilibrated 
with 50 mM sodium phosphate, pH 7.0, 150 mM NaCl under aerobic conditions. The 
column was eluted with that same buffer at a flow rate of 0.25 ml/min and the protein 
elution profile was determined by monitoring absorbance at 280 nm. Gel filtration 
standards from Bio-Rad were used to construct a calibration curve of log MW versus 
retention time. 
Identification of the flavin cofactor bound to PduS-His6. Purified PduS-His6 (in 
Ni-NTA elution buffer) was boiled for 10 min to release the flavin cofactor. The 
suspension was rapidly cooled on ice and denatured protein was removed by 
centrifugation at 16,000 x g for 5 min using an Eppendorf 5415D centrifuge. 
Flavin-containing supernatant was filtered with a 0.22 μm Millex-GV syringe filter 
(Millipore, Bedford, MA) and analyzed using a Varian ProStar HPLC system (Palo Alto, 
CA), consisting of a model 230 solvent delivery module, a model 430 autosampler, a 
model 325 UV-visible detector and a Microsorb-MV 100-5 C18 column. The column was 
developed with 19 ml linear gradient from 7% to 90% methanol in 5 mM ammonium 
acetate pH 6.0 at a flow rate of 1 ml/min. Flavins were detected by monitoring 
absorbance at 450 nm. Authentic FAD and FMN were used as standards and flavins 
separated by HPLC were collected and analyzed by MS. 
Iron and sulfide content assays. Non-heme iron assays were carried out by using the 
method of Fish (79). Acid-labile sulfide assays were performed with a modified Beinert’s 
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method (22, 41) under anaerobic conditions except that 10 μl instead of 2 μl of FeCl3 (23 
mM in 1.2 M HCl) solutions were used at the last step for color development. 
Cob(III)alamin and cob(II)alamin reduction assays. Enzyme assays were performed 
under anaerobic conditions as described previously with some modifications (194). All 
reactions were initiated by addition of NADH or iodoacetate to assay mixtures except 
where noted in the text. Cob(III)alamin reductase assays contained 50 mM CHES/NaOH 
(pH 9.5), 1.6 mM KH2PO4, 0.5 mM MgCl2, 0.5 mM NADH, 0.2 mM OH-Cbl and 
cob(III)alamin reductase as indicated in the text. The conversion of OH-Cbl to 
cob(II)alamin was monitored spectrophotometrically by measuring the absorbance 
decrease at 525 nm and quantified using Δε525 = 4.9 mM-1 cm-1 (194).  
Cob(II)alamin reductase activity was assayed using two methods. In method one, 
iodoacetate was used as a chemical trap for cob(I)alamin. Iodoacetate reacts rapidly and 
quantitatively with cob(I)alamin to form carboxymethylcobalamin (CM-Cbl) with a 
concomitant absorbance increase at 525 nm (Δε525 = 5.3 mM–1 cm–1) (26). Assay mixtures 
contained 50 mM CHES/NaOH (pH 9.5), 1.6 mM KH2PO4, 0.5 mM MgCl2, 0.5 mM 
NADH, 0.2 mM cob(II)alamin, 0.5 mM iodoacetate, and cob(II)alamin reductase. The 
second method for measuring cob(II)alamin reduction was a coupled assay with the PduO 
adenosyltransferase as described in a prior report (194). Assay mixtures contained the 
same components as assay one except that 0.5 mM iodoacetate was replaced by 0.5 mM 
ATP and 1.6 μM PduO adenosyltransferase purified from BE118 as described (111). 
PduO converts ATP and cob(I)alamin to AdoCbl which occurs with an increase in 
absorbance at 525 nm (Δε525 = 4.8 mM–1cm–1). 
Growth studies. Growth studies were performed using a Synergy HT Microplate 
reader (BioTek, Winooski, VT) as previously described (139). For growth of strains 
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carrying plasmids, media were supplemented with 100 μg/ml ampicillin. For 
complementation studies, IPTG was used at 10 μM to induce expression of genes cloned 
into pLAC22. 
Pdu MCP purification. Cells were grown at 37 °C with shaking at 275 rpm to an 
OD600 of 1.0-1.2 in 400 ml NCE medium supplemented with 1 mM MgSO4, 0.5% 
succinate, and 0.6% 1,2-PD inoculated with 2 ml of an overnight LB culture. Cells were 
harvested by centrifugation at 6,000 x g for 10 min at 4 °C. Then, MCPs were purified as 
previously described and stored at 4 °C until used (94). 
MALDI-TOF MS-MS. Bands of interest were excised from SDS-PAGE gels and 
digested “in-gel” with trypsin. The resulting peptides were extracted and analyzed by 
MALDI-TOF MS-MS using a QSTAR XL quadrupole TOF mass spectrometer (AB/MDS 
Sciex, Toronto, Canada) equipped with an oMALDI ion source. CHCA was used as 
matrix and the mass spectrometer was operated in the positive ion mode. Mass spectra for 
MS analysis were acquired over m/z 600 to 2200. After every regular MS acquisition, two 
MS-MS acquisitions were performed against most intensive ions. The molecular ions 
were selected by information dependent acquiring program in the quadrupole analyzer 
and fragmented in the collision cell. All spectra were processed by MASCOT 
(MatrixScience, London, UK) database search. 
Two-hybrid analyses. The BacterioMatch II Two-Hybrid System (Stratagene) was 
used to detect the potential interactions between the PduS and PduO proteins in vivo 
following manufacturer’s instructions.  
2.4. Results 
Sequence analysis. The PduS protein of S. enterica is composed of 451 amino acid 
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residues. Over 100 PduS homologues present in GenBank are associated with 1,2-PD 
degradation based on gene proximity. PduS also has 43% sequence identity with the RnfC 
subunit of NADH:ubiquinone oxidoreductase (RnfABCDEG) encoded by the bacterial 
rnf operon (199), and the N-terminus of PduS (amino acids 1-165) has 25% amino acid 
identity with the Nqo1 (NDUFV1 in mammals) subunit of the bacterial and mitochondrial 
NADH-quinone oxidoreductase complex I (168, 197, 204). PduS has several conserved 
binding sites for substrates and cofactors, including an NADH-binding motif 
(28GXGX2G33 where X denotes any amino acid) (37), an FMN-binding motif 
(120YX2G[D/E]E125) (125, 197) and two canonical [4Fe-4S] motifs (264CX2CX2CX3C274 
and 309CX2CX2CX4C320)  (86, 132) (Fig. 2.2A, B). PduS also has several conserved 
domains. An N-terminal glycine-rich loop (25GX2GXGGAG[F/L]P[A/T]X2K39), proposed 
to bind the adenosine diphosphate (ADP) moiety of NADH, is conserved among PduS, 
RnfC and Nqo1 (Fig. 2.2C) (197). A non-classical Rossmann fold following the Gly-rich 
loop is proposed to bind FMN (197). A soluble ligand-binding β-grasp fold (SLBB) 
domain which belongs to a newly defined superfamily is proposed to bind cobalamin in 
PduS (46). The two [4Fe-4S] motifs of PduS are found in a Fer4 domain (PF00037) (46). 
PduS has a C-terminal sandwich barrel hybrid motif (SBHM). Some SBHM domains 
carry covalently associated ligands including biotin and lipoate, but PduS has no known 
covalently bound ligands (46, 108). 
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A 
 
FIG. 2.2. Sequence analyses of PduS. (A) Structure-based sequence alignment by clustal X2 and 
PSIPRED. α-helix and β-strand are represented by coil and arrow, respectively. CfPduS, PduS from 
Citrobacter freundii (GI: 171854200); Ec, Escherichia coli (GI: 157159374); Li, Listeria innocua (GI: 
16800175); Ri, Roseburia inulinivorans (GI: 225376079); Se, Salmonella enterica (GI: 16765383); Ye, 
Yersinia enterocolitica (GI: 123442959); TaRnfC, RnfC from Thermanaerovibrio acidaminovorans 
(GI: 269791702). (B) The domain architecture of PduS protein (46). (C) Sequence logo of the amino 
acid residues (present at positions 25-39 in PduS of S. enterica) in the glycine-rich region used for 
nucleotide-binding. Polar residues are in green, basic in blue, acidic in red, and hydrophobic in black.  
B C
Expression and purification of PduS-His6 protein. E. coli strain BE1374 was 
constructed to produce high levels of C-terminal-His6-tagged PduS protein via a T7 
expression system. This strain produced relatively large amounts of protein near the 
expected molecular mass of PduS-His6 (49.2 kDa) and the major portion of this protein 
was found in the soluble fraction of cell extracts (Fig. 2.3). In contrast, cell extracts from 
a control strain containing the expression plasmid without insert (BE1355) produced 
much less protein near 49.2 kDa. PduS-His6 was purified under both aerobic and 
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anaerobic conditions by Ni-NTA affinity chromatography. Based on SDS-PAGE 
anaerobically purified PduS-His6 protein was about 90% homogenous (Fig. 3, lane 4), 
and a similar level of purity was obtained for aerobically purified enzyme. 
 
FIG. 2.3. SDS-PAGE analysis of the anaerobic purification of PduS-His6 from BE1374. Lane 1, 
protein standards; lane 2, 12 μg whole-cell extract; lane 3, 12 μg soluble fraction; lane 4, 3 μg purified 
PduS-His6. The gel was 12% polyacrylamide and was stained with Coomassie. 
Oligomeric state of PduS-His6 protein. Size exclusion chromatography of 
anaerobically purified PduS-His6 showed a major peak and a small shoulder which 
corresponded to a monomer with an apparent molecular mass of 49 kDa and a dimer of 
98 kDa, respectively (Fig. 2.4A). Chromatography of aerobically purified PduS-His6 
displayed a major peak and a larger shoulder indicating that the dimer comprised a larger 
proportion in aerobically purified PduS-His6 (Fig. 2.4B). The small amount of 
dimerization observed following aerobic purification may have resulted from the 
formation of intermolecular disulfide bonds perhaps involving cysteine residues freed 
from the iron-sulfur clusters which are oxygen-labile.  
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A 
B 
FIG. 2.4. Oligomeric state and molecular mass determination of PduS-His6 by size exclusion 
chromatography. PduS-His6 is predominant in monomeric fractions. (A) Profile of anaerobically 
purified PduS-His6. (B) Profile of aerobically purified PduS-His6.  
Characterization of the flavin cofactor of PduS-His6. Aerobically Purified 
PduS-His6 was yellow in color, and its UV-visible spectrum exhibited peaks at 375 and 
450 nm and a shoulder at 480 nm indicative of a flavin cofactor (Fig. 2.5).  
To determine the binding stoichiometry and the type of flavin (FAD or FMN), purified 
PduS-His6 was denatured with heat and the released cofactors were analyzed by HPLC 
and MS. The flavin extracted from PduS-His6 eluted at 9.96 min by reverse phase HPLC, 
which was similar to the retention time for authentic FMN (9.86 min) (Fig. 2.6). In 
contrast, FAD eluted at 8.90 min (Fig. 2.6). In addition, further studies showed that the 
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flavin released from PduS-His6 co-migrated with authentic FMN by reverse phase HPLC 
following co-injection (Fig. 2.6).  
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FIG. 2.5. UV-visible spectrum of purified PduS-His6 (solid line) in comparison to that of authentic 
FMN (dashed line). The absorbance peaks at 375 and 450 nm with a shoulder at 480 nm are diagnostic 
of flavin. 
 
FIG. 2.6. Reverse phase HPLC analyses of flavin released from PduS-His6. Flavins were detected by 
absorbance at 450 nm. a, authentic FAD; b, boiled authentic FAD; c, authentic FMN; d, flavin released 
from PduS-His6; e, authentic FMN plus flavin from PduS-His6. The absorbance profiles shown were 
determined by separate HPLC analyses then overlaid. 
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Lastly, HPLC and MS were used to confirm and quantify the flavin cofactor of 
PduS-His6. The mass spectrum of the flavin released from purified PduS-His6 showed a 
major peak with an m/z of 455.1 corresponding to that of FMN (Fig. 2.7). Quantitation by 
HPLC determined a stoichiometry of 0.93:1, (FMN:PduS-His6) indicating that PduS-His6 
binds 1 molecule of FMN per monomer. 
 
B A 
FIG. 2.7. MS analyses of the flavin extracted from purified PduS-His6. (A) Authentic FMN. (B) Flavin 
extracted from PduS-His6 and purified by HPLC. The MS spectrum of flavin from PduS-His6 
displayed a peak with an m/z of 455.1 corresponding to that of authentic FMN. 
Flavin cofactors may be covalently or non-covalently bound to flavoproteins. The 
observation that flavin was released from PduS-His6 by heat treatment indicated 
non-covalent binding of FMN to PduS-His6. To further investigate, we used SDS-PAGE. 
Covalently bound flavins remain protein-associated during SDS-PAGE and can be 
detected by fluorescence following UV illumination of gels (207). In contrast, 
non-covalently bound flavins are not detected. The FMN cofactor of PduS-His6 could not 
be detected by UV illumination of SDS-PAGE gels indicating non-covalent binding (Fig. 
2.8). In contrast, the flavin of sarcosine oxidase from Corynebacterium, which is known 
to be covalently bound (242), co-migrated with the protein during SDS-PAGE and was 
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readily detected by UV illumination (Fig. 2.8). Thus, results indicate that FMN is 
non-covalently bound to PduS-His6.  
 
 
FIG. 2.8. PduS binds FMN non-covalently. (A) SDS-PAGE of PduS-His6 (lane 2) and sarcosine 
oxidase from Corynebacterium sp. (lane 3). (B) Detection of flavin fluorescence in PduS-His6 (lane 4) 
and sarcosine oxidase from Corynebacterium sp. (lane 5) on an SDS-PAGE gel. The fluorescence of 
the corynebacterial sarcosine oxidase was due to the FMN covalently bound to the β subunit (SoxB). 
Fluorescence of PduS-His6 following SDS-PAGE was undetectable indicating that FMN binding is 
non-covalent. To detect fluorescence, the SDS-PAGE gel was soaked with 7% acetic acid for 15 min 
followed by spraying with performic acid, and then illuminated with UV light (λ = 365 nm) (207). 
Iron and sulfide contents. To test the presence of iron-sulfur clusters in PduS protein, 
the contents of iron and sulfide in PduS-His6 were measured. The results indicated that 
anaerobically purified PduS-His6 contains 7.6 ± 0.3 mol of iron and 7.1 ± 0.5 mol of 
acid-labile sulfide per mol of PduS-His6 monomer, which is consistent with the motif 
prediction result that PduS sequence contains two [4Fe-4S] binding sites. Whereas 
aerobically purified PduS-His6 contains 3.0 ± 0.3 mol of iron and 2.8 ± 0.3 mol of sulfide 
per mol of PduS monomer, suggesting that the iron-sulfur clusters of PduS are 
oxygen-labile. 
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In vitro cob(III)alamin and cob(II)alamin reductase activities of the PduS-His6 
enzyme. PduS-His6 was purified using strict anaerobic conditions and tested for 
cob(III)alamin and cob(II)alamin reductase activities after each purification step (Table 
2.2). The whole-cell extract from the PduS-His6 expression strain (BE1374) exhibited 
about 350-fold higher cob(III)alamin reductase activity (3.9 ± 0.3 μmol min-1 mg-1) than 
did extracts from the control strain carrying the expression plasmid without insert 
(BE1355) (11.0 ± 3.1 nmol min-1 mg-1). Purification of the PduS-His6 protein by 
anaerobic Ni-NTA chromatography increased the cob(III)alamin reductase specific 
activity approximately 11-fold to 42.3 ± 3.2 μmol min-1 mg-1.  
Assays showed that the PduS-His6 protein also catalyzed the reduction of cob(II)alamin 
to cob(I)alamin. Soluble cell extracts of expression strain BE1374 had 4.9 ± 0.5 nmol 
min-1 mg-1 cob(II)alamin reductase activity when iodoacetate was used to trap 
cob(I)alamin and 4.3 ± 0.4 nmol min-1 mg-1 in a coupled assay with the PduO 
adenosyltransferase (see assay procedures in the methods section). In contrast, control 
extracts from BE1355 lacked detectable cob(II)alamin reductase activity. Purification of 
the PduS-His6 protein by anaerobic Ni-NTA chromatography increased the cob(II)alamin 
reductase specific activity about 11-fold to 54.5 ± 4.2 nmol min-1 mg-1 by the iodoacetate 
assay and about 9-fold to 40.3 ± 4.1 nmol min-1 mg-1 by the PduO-linked assay.  
PduS-His6 was also purified under aerobic conditions. Aerobically purified PduS-His6 
retained about 40% activity for both cob(III)alamin and cob(II)alamin reduction. The 
reduced activity following aerobic purification was likely due to oxidative damage to 
catalytic sites such as the iron-sulfur centers predicted from sequence analysis (Fig. 2). 
TABLE 2.2. Anaerobic purification of PduS-His6. 
Cob(III)alamin reductase Cob(II)alamin reductase 
Purification step 
Total 
protein 
(mg) 
Specific activity 
(μmol min-1 mg-1) 
Total activity 
(μmol min-1) 
Purification 
fold 
Specific activity 
(nmol min-1 mg-1)
Total activity 
(nmol min-1) 
Purification 
fold 
Whole-cell extract 220 3.9 ± 0.3 858 1 4.4 ± 0.4 968 1 
Soluble fraction 166 4.2 ± 0.4 697 1.1 4.9 ± 0.5 813 1.1 
Ni-NTA eluate 1.6 42.3 ± 3.2 67.7 10.8 54.5 ± 4.2 87.2 12.4 
a0.5 mM iodoacetate was used to trap produced cob(I)alamin. 
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The C-terminal His6-tag had no obvious effect on PduS enzymatic activities based on 
the comparisons of the reductase activities in the whole-cell extracts and soluble fractions 
of BE1374 and BE1356, which respectively express PduS-His6 and wild-type PduS. 
Reaction requirements. To determine the PduS reaction requirements, key assay 
components were individually omitted. For cob(III)alamin reduction, there was no 
activity in the absence of NADH or OH-Cbl. In the absence of PduS-His6, cob(III)alamin 
reduction occurred at a rate of 3.5 ± 0.5 nmol min-1 (more than 1100-fold slower than the 
PduS-catalyzed reaction) due to chemical reduction by NADH. The PduS-His6 
cob(III)alamin reductase lacked measurable activity with CN-Cbl. In the cob(II)alamin 
reduction assays, controls showed that no detectable CM-Cbl was formed in the absence 
of NADH, cob(II)alamin, PduS-His6, or iodoacetate. Similarly, in linked assays with the 
PduO adenosyltransferase, no AdoCbl was measurable in the absence of NADH, 
cob(II)alamin, PduS-His6, ATP or PduO. Moreover, no cob(I)alamin production could be 
directly observed by monitoring absorbance at 388 nm (113) in the absence of trapping 
agents (iodoacetate or PduO and ATP).  
Effects of pH, temperature, and divalent metal ions on cobalamin reductase 
activities of PduS-His6. To determine the effects of pH on the activity of purified 
PduS-His6 cob(III)alamin and cob(II)alamin reductase activities were measured at pH 
values ranging from 7.0 to 10.5 with an interval of 0.25 pH units using anaerobically 
purified PduS-His6. Under the conditions used, the PduS-His6 cob(III)alamin reductase 
activity was maximal at pH 9.5, and this value was set as 100%. Sharp decreases in 
activity were observed at pH 9.0 and pH 10.0 (51.4 and 40.0% drop, correspondingly), 
and further decreases were displayed at lower and higher pH values. In contrast, pH had a 
relatively small effect on PduS-His6 cob(II)alamin reductase activity. The highest activity 
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was measured at pH 9.0-9.5 with 17% decrease at pH 8.0 and 10.0. These results suggest 
that an ionizable group contributes to cob(III)alamin reductase activity but not to 
cob(II)alamin reduction. The buffer used to test pH effects was that standard assay buffer, 
CHES/NaOH. 
To determine the effects of temperature on the activity of purified PduS-His6, 
cob(III)alamin and cob(II)alamin reductase activities were measured under standard assay 
conditions with the temperature set at 25, 30, 37, 42, or 50 °C. The relative cob(III)alamin 
reductase specific activities were as follows: 47.2% at 25 °C, 64.3% at 30 °C, 100% at 37 
°C, 92.0% at 42 °C, 78.4% at 50 °C, while PduS-His6 cob(II)alamin reductase activity 
had a different profile: 24.1% at 25 °C, 38.9% at 30 °C, 73.9% at 37 °C, 100% at 42 °C, 
80.6% at 50 °C. The different temperature profiles for the cob(III)alamin and 
cob(II)alamin reductase activities of PduS, together with the different pH profiles 
tentatively suggest their reduction may occur at different catalytic sites. 
To determine the effect of divalent metal ions on PduS-His6 enzymatic activities, seven 
chloride salts including CaCl2, CdCl2, CoCl2, MgCl2, MnCl2, NiCl2, ZnCl2, were tested 
separately at 0.5 mM in the activity assays at 37 °C and pH 9.5. Mg2+ and Ca2+ ions 
significantly stimulated PduS-His6 cob(III)alamin reductase activity, by 1.35- and 1.5-fold 
respectively, compared to the activity measured with no added divalent ions. Addition of 
Mn2+ ions resulted in a somewhat smaller enhancement of 1.25-fold on cob(III)alamin 
reductase activity. Ni2+ was slight inhibitory resulting in an 8% decrease in activity 
relative to the unsupplemented control. PduS-His6 cob(II)alamin reductase activity was 
stimulated around 1.1-fold by Ca2+, Mg2+, and Mn2+ ion, and was inhibited by Ni2+ which 
resulted in a 60% drop in activity. Cd2+, Co2+, and Zn2+ ions abolished both the 
cob(III)alamin and cob(II)alamin reductase activities of PduS-His6. 
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Preference for the electron donor of PduS-His6. To determine the cofactor specificity 
of PduS-His6 both cobalamin reductase activities were assayed in the presence of either 
NADH or NADPH at 0.5 mM. Results showed that purified PduS-His6 enzyme had 
16.9% relative activity for both activities with NADPH compared to NADH which was 
the preferred substrate. 
Linearity of the reactions. The effects of PduS-His6 concentration on enzymatic 
activities were determined. Cob(III)alamin reduction was proportional to PduS-His6 
concentration from 5 to 50 nM when 0.5 mM NADH and 0.2 mM OH-Cbl were used as 
substrates. Linear regression yielded an R2 value of 0.999. Cob(II)alamin reduction, 
measured in nanomoles of CM-Cbl generated per minute, was linear from 0.2 to 2 μM 
PduS-His6 (R2 = 0.998) when the assay mixture contains 0.5 mM NADH, 0.2 mM 
cob(II)alamin, and 0.5 mM iodoacetate as the cob(I)alamin trapping agent. 
Kinetic analysis of PduS-His6 activities. Steady-state kinetic studies for 
cob(III)alamin and cob(II)alamin reduction were performed using purified PduS-His6 
with varied concentrations of one substrate and a fixed concentration of the other 
substrate. Kinetic parameters were obtained by non-linear curve fitting to the 
Michaelis-Menten equation v = (Vmax [S])/(Km + [S]) using GraphPad Prism 5 Software 
(GraphPad Software, San Diego, CA). For cob(III)alamin reduction, the apparent Km 
values for NADH and OH-Cbl were 10.1 ± 0.7 μM and 67.5 ± 8.2 μM, respectively (Fig. 
9; Table 3). The enzyme Vmax was 43.1 ± 0.5 or 46.6 ± 1.6 μmol min–1 mg–1 when OH-Cbl 
or NADH were held at constant levels, respectively. The fixed concentrations of OH-Cbl 
and NADH used were 200 µM and 500 µM, respectively. 500 µm NADH is 50-fold 
higher than the apparent Km (98% saturating) and 200 µM OH-Cbl is 3-fold higher than 
the apparent Km (75% saturating) which was the highest level that could be used while 
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still retaining a linear response from the spectrophotometer.  
A 
B 
 
FIG. 2.9. Kinetics of cob(III)alamin and cob(II)alamin reductions by purified PduS-His6. A, 
Cob(III)alamin reduction assays performed with 25 nM anaerobically purified PduS-His6. B, 
Cob(II)alamin reduction assays performed with 1 μM anaerobically purified PduS-His6 protein in the 
presence of 0.5 mM iodoacetate. When the concentration of NADH was varied, OH-Cbl or 
cob(II)alamin was used at 0.2 mM. When the concentration of OH-Cbl or cob(II)alamin was varied, 
NADH was held at 0.5 mM. The inserts show Lineweaver-Burk (double-reciprocal) plots. 
TABLE 2.3. Kinetic parameters for cob(III)alamin and cob(II)alamin reduction by purified PduS-His6.  
Reaction Variable substrate 
Kma 
(μM) 
Vmaxa 
(nmol min-1 mg-1)
kcat 
(s-1) 
kcat/Km 
(μM-1 s-1)
NADH 10.1 ± 0.7 (43.1 ± 0.5) x 103 35.3 ± 0.4 3.5 Cob(III)alamin 
reductionb OH-Cbl 67.5 ± 8.2 (46.6 ± 1.6) x 103 38.2 ± 1.3 0.57 
NADH 27.5 ± 2.4 56.8 ± 1.1 (46.6 ± 0.9) x 10-3 1.7 x 10-3Cob(II)alamin 
reductionc cob(II)alamin 72.4 ± 9.5 64.7 ± 3.6 (53.0 ± 3.0) x 10-3 0.7 x 10-3
aThe values of Km and Vmax were from non-linear regression using GraphPad Prism 5. 
bCob(III)alamin reduction assays were performed with 25 nM anaerobically purified PduS-His6. 
cCob(II)alamin reduction assays were performed with 1 μM anaerobically purified PduS-His6 protein 
in the presence of 0.5 mM iodoacetate.  
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The kinetics of cob(II)alamin reduction were determined using iodoacetate to trap 
cob(I)alamin. Non-linear regression indicated an apparent Km of 27.5 ± 2.4 μM and 72.4 ± 
9.5 μM for NADH and cob(II)alamin, respectively (Fig. 2.9; Table 2.3). The enzyme Vmax 
was 56.8 ± 1.1 nmol min–1 mg–1 when the cob(II)alamin concentration was held constant 
and 64.7 ± 3.6 nmol min–1 mg–1 when NADH was held at a saturating level. For the above 
kinetic studies, NADH and cob(II)alamin were used at fixed concentrations of 500 µM 
and 200 µM, respectively.  
Phenotype and complementation of a pduS deletion mutation. To investigate the 
function of PduS in vivo, we measured the growth of a pduS deletion mutant (BE1352) on 
1,2-PD minimal medium.  
BE1352 grew slowly (64% wild-type rate) on 1,2-PD minimal medium supplemented 
with saturating levels of CN-Cbl (100 nM) (Fig. 2.10A). At limiting concentrations of 
CN-Cbl (20 nM), the pduS deletion mutant grew more slowly (61%) and to a lower cell 
density than wild-type S. enterica (Fig. 2.10B). Complementation analysis was also 
conducted. Production of PduS from pLAC22 fully corrected the slow growth phenotype 
of the ΔpduS mutant at saturating CN-Cbl (Fig. 2.10C) and limiting CN-Cbl (not shown) 
confirming that slow growth was due to the pduS deletion, and not due to polarity or an 
unknown mutation. The growth curves shown in Fig. 2.10 A-C were all repeated at least 
three times with triplicate cultures. The slow growth phenotype of the pduS deletion 
mutant supports a role for PduS in cobalamin reduction in vivo as further described in the 
discussion section. 
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A 
B 
C 
FIG. 2.10. Phenotype and complementation of a pduS deletion mutation. Cells were grown in NCE 
minimal medium with 1,2-PD as a sole carbon and energy source. (A) The pduS deletion moderately 
impaired growth on 1,2-PD supplemented with 100 nM CN-Cbl. (B) The pduS deletion impaired 
growth and decreased cell density on 1,2-PD with limiting CN-Cbl (20 nM). (C) The pduS deletion 
was complemented by ectopic expression of pduS at 100 nM CN-Cbl. 10 μM IPTG was used to induce 
production of PduS from pLAC22.  
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Interaction between PduS and PduO. Prior studies suggested the PduS and PduO 
interact in vitro which makes sense because they catalyze sequential reactions in 
cobalamin recycling (194). To examine the potential interactions between PduS and PduO 
in vivo, two-hybrid analyses were performed. For the system used, detection of 
protein-protein interactions is based on transcriptional activation of the yeast HIS3 
reporter gene which confers 3-amino-1,2,4-triazole (3-AT) resistance. In application, a 
reporter strain is co-transduced with a target and bait plasmid pair, and the number of 
3-AT resistant colonies estimates the strength of the protein-protein interaction.  
To test for a PduS-PduO interaction, the number of colonies on non-selective and 
selective (3-AT) media was counted at different dilutions after co-transformation (Table 
2.4). When PduO and PduS were produced from the target (pTRG) and bait (pBT) 
plasmids or vice versa a substantial number of 3-AT resistant co-transformants were 
obtained. In contrast, very few 3-AT resistant transformants were observed in controls 
that lacked either pduO or pduS (Table 2.4). These results indicated that PduS interacts 
with PduO in vivo.  
TABLE 2.4. Two-hybrid analysis of PduS-PduO interactions. 
 Number of coloniesa  
 Non-selective medium Selective medium (3-AT) 
Plasmid pair 1/100 1/1000 1/10 1/1000 
pBT-LGF2/pTRG-Gal11b TNTCc ~2000 TNTC ~2000 
pBT-pduS/pTRG-pduO >2000 255 >2000 152 
pBT-pduO/pTRG-pduS >2000 296 >2000 129 
pBT-pduS/pTRG >2000 410 0 0 
pBT/pTRG-pduS >2000 564 1 0 
pBT-pduO/pTRG >2000 170 2 0 
pBT/pTRG-pduO >2000 400 3 0 
aNumber of colonies formed following co-transformation of the reporter strain with the bait and target 
plasmids on selective and nonselective media at the dilution indicated. 
bLGF2 and Gal11 are a positive control known to strongly interact.  
cTNTC: Too numerous to count. 
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A B 
 
FIG. 2.11. PduS is a component of the Pdu MCP. (A) 10-20% SDS-PAGE gel stained with Coomassie 
brilliant blue. Lane 1, molecular mass markers; lane 2, 10 μg Pdu MCPs purified from wild-type 
Salmonella. (B) Western blot for PduS. Lanes 1 and 2, 10 μg whole-cell extract or purified MCPs from 
wild-type; lanes 3 and 4, 10 μg whole-cell extract or purified MCPs from BE1352 (ΔpduS).  
PduS is a component of Pdu MCP. To determine the cellular location of PduS, MCPs 
purified from wild-type S. enterica and pduS deletion mutant BE1352, were analyzed by 
SDS-PAGE, MALDI-TOF MS-MS, and Western blot. A band near the expected 
molecular mass of PduS (48.4 kDa) and close to the PduP band at 49.0 kDa, was observed 
on an SDS-PAGE gel of MCPs purified from the wild-type strain (Fig. 2.11A lane 2). 
This band was further analyzed by MALDI-TOF MS-MS. Five sequences (KSHPLIQRR, 
RAIDALTPLLPDGIRL, KVDQQLMWQQAARL, RQHIGASAVANVAVGERV, 
RHLIGHELSPHLLVRA) identified by MS-MS of a trypsin digest matched the PduS 
protein indicating it is a component of purified Pdu MCPs. In addition, Western blot with 
PduS antisera detected a band near 48 kDa in MCPs purified from wild type S. enterica 
(Fig. 2.11B lane 2), while no PduS band was detected in MCPs purified from the pduS 
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deletion mutant (Fig. 2.11B lane 4). Furthermore, when similar amounts of protein were 
analyzed, Western blot easily detected PduS in purified MCPs but not in crude cell 
extracts (Fig. 2.11B lane 2 and 1). This indicated that purified MCPs were substantially 
enriched in PduS. Cumulatively, these results show that PduS protein is a component of 
Pdu MCPs.  
2.5. Discussion 
In previous studies, an E. coli strain was constructed that produced high levels of the 
PduS enzyme of S. enterica (194). Crude cell extracts from this strain had substantially 
increased cob(III)alamin and cob(II)alamin reductase activities suggesting that the PduS 
enzyme played a role in cobalamin assimilation and recycling (194). Very recently, the 
PduS enzyme was purified and shown to be a flavoprotein that can supply electrons for 
the synthesis of AdoCbl by the human and Lactobacillus ATR enzymes; however, PduS 
was not further characterized (147). In this report, C-terminally His6-tagged PduS protein 
was purified and characterized more extensively. Results showed that PduS is a 
flavoprotein that contains 1 FMN per monomer. Anaerobically purified PduS-His6 protein 
exhibited cob(III)alamin and cob(II)alamin reductase activities of 42.3 μmol min-1 mg-1 
and 54.5 nmol min-1 mg-1, respectively. Although, the cob(II)alamin reductase activity is 
776-fold lower than the cob(III)alamin reductase activity, it is reasonable to infer that this 
activity is relevant in vivo. The midpoint potentials of cob(III)alamin/cob(II)alamin (+240 
mV) and cob(II)alamin/cob(I)alamin (-610 mV) (13, 136) rationally account for the 
incongruity between the two activities. AdoCbl is needed only in very small quantities, 
generally from 1-10 μM in prokaryotes (202). At least one other enzyme with a 
well-documented role in AdoCbl synthesis (the CobA ATR) was reported to have a 
specific activity of 53 nmol min-1 mg-1 (221) which is very close to the cob(II)alamin 
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reductase activity of PduS reported here. Moreover, the disparity in cob(III)alamin and 
cob(II)alamin reductase activities of PduS is similar to that reported for the CobR corrin 
reductase from Brucella melitensis which is unrelated in amino acid sequence to PduS but 
catalyzes similar reactions (127). Thus, we infer that the lower, cob(II)alamin reductase 
activity of PduS is within a physiologically relevant range.  
Kinetic studies of purified PduS-His6 were also performed. The apparent Km values of 
PduS-His6 were 67.5 μM and 10.1 μM for OH-Cbl and NADH respectively in 
cob(III)alamin reduction, and 72.4 μM for cob(II)alamin and 27.5 μM for NADH in 
cob(II)alamin reduction. Typical intracellular cobalamin levels are about 1 to 10 µM in 
prokaryotic organisms (202) and the levels of nicotinamide coenzymes are 1-3 mM (158). 
This suggests that in vivo NADH would be saturating and cobalamin would be limiting 
for PduS activity; however, results presented in this report indicate that PduS is a 
component of the Pdu MCP and hence may reside in the MCP lumen where the local 
cobalamin concentration is unknown but might be elevated relative to the cytoplasm of 
the cell. Thus, the Km values of PduS for cobalamins might reflect its localization within 
the lumen of the Pdu MCP. 
Several other systems capable of reducing cobalamin in vitro have been previously 
described (81, 82, 127, 147, 194). The reduction of cob(III)alamin to cob(II)alamin is 
facile and certainly occurs to some extent in the cytoplasm of prokaryotic cells (which is 
a strongly reducing environment) without the requirement for a specific reductase (82). In 
addition, several flavoproteins as well as FMNH2 and FADH2 reduce cob(III)alamin to 
cob(II)alamin in vitro and may contribute to cob(III)alamin reduction in vivo (82, 147, 
194). The reduction of cob(II)alamin to cob(I)alamin is more difficult due to extremely 
low redox potential of the cob(II)alamin/cob(I)alamin couple (-610 mV) (136). Prior 
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studies showed that FADH2, FMNH2, ferredoxin NADP+ reductase (Fpr), flavodoxin A 
(FldA), flavin:NADH reductase (Fre) as well as flavoproteins with no known 
involvement in B12 metabolism can provide electrons for cob(II)alamin reduction in vitro 
in the presence of ATR (82, 147). Results indicated that these systems specifically reduce 
4-coordinate ATR-bound cob(II)alamin whose midpoint potential is about 250 mV higher 
than that of 5-coordinate cob(II)alamin (147, 214). In this report, we showed that purified 
PduS is able to reduce both cob(III)alamin and cob(II)alamin in the absence of additional 
proteins. The reduction of cob(II)alamin to cob(I)alamin was detected by trapping 
cob(I)alamin with iodoacetate and by using a coupled assay with the PduO ATR. In both 
assays, the rates of cob(II)alamin reduction were similar, 54.5 and 40.3 nmol min-1 mg-1, 
respectively. This showed that ATR was nonessential for cob(II)alamin reduction by PduS. 
This raises the question of how PduS overcomes the redox-potential-barrier for 
cob(II)alamin reduction. One possibility is that PduS binds cob(II)alamin and converts it 
to the 4-coordinate form prior to reduction. 
The fact that cobalamin can be reduced by FMNH2, FADH2 and various flavoproteins 
raises the question of the relative contributions of these systems in vivo. To examine the 
role of PduS in vivo, we tested the effects of a pduS deletion mutation on 
AdoCbl-dependent growth on 1,2-PD with saturating or limiting CN-Cbl (Fig. 2.10A, B). 
Under both conditions, the pduS deletion impaired growth, indicating that PduS was 
required to support the maximal rate of 1,2-PD degradation under the conditions used. 
The likely reason that the pduS deletion exhibited only a partial growth defect is that S. 
enterica has multiple cobalamin reducing systems as described above. A similar partial 
growth defect on 1,2-PD was observed following genetic deletion of the Salmonella 
PduO ATR which is partially redundant with the CobA enzyme (113). Thus, results 
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presented here indicate that PduS provides additional cobalamin reduction capacity 
required for maximal growth on 1,2-PD and may also be important within the confines of 
the Pdu MCP as discussed below.  
 
FIG. 2.12. Proposed model for cobalamin recycling inside the Pdu MCPs of S. enterica. Prior studies 
showed that AdoCbl-dependent diol dehydratase (PduCDE) resides in the lumen of the Pdu MCP. 
PduCDE is subject to mechanism-based inactivation in which damaged Cbl cofactor (OH-Cbl) 
becomes tightly enzyme bound. Diol dehydratase reactivase (PduGH) releases OH-Cbl from PduCDE. 
Then, OH-Cbl is reduced by PduS to cob(I)alamin and adenosylated to AdoCbl by the PduO 
adenosyltransferase. AdoCbl spontaneously associates with apo-PduCDE to form active holoenzyme. 
The recycling of OH-Cbl is required to maintain the activity of PduCDE and hence is essential for the 
degradation of 1,2-propanediol as a carbon and energy source. The finding that PduS is a component 
of the Pdu MCP suggests that cobalamin recycling can occur entirely within the MCP lumen.  
Results presented here demonstrated that PduS is associated with Pdu MCPs. PduS was 
identified as a component of purified MCPs following SDS-PAGE (Fig. 2.11A) and 
MS-MS. In addition, Western blot showed that purified MCPs were substantially enriched 
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in PduS which established a specific association between PduS and the Pdu MCP (Fig. 
2.11B). Furthermore, two-hybrid studies indicated an in vivo interaction between PduS 
and PduO which was previously localized to the Pdu MCP (94). Prior proteomics studies 
missed PduS as an MCP component (94). This was likely due to the difficulty in 
separating PduS from the PduP enzyme (a major MCP component) by SDS-PAGE (Fig. 
2.11A). Alternatively, PduS may have been missed due to its high pI (8.82) which would 
have resulted in migration to the edge of the gel or off during isoelectric focusing step of 
2D electrophoresis used in prior studies (94). Thus, substantial evidence indicates PduS is 
a component of the Pdu MCP. This establishes that all the enzymes needed for cobalamin 
recycling are components of the Pdu MCP suggesting that cobalamin recycling can occur 
entirely within the lumen of the Pdu MCP (Fig. 2.12). The AdoCbl-dependent diol 
dehydratase (PduCDE) required for 1,2-PD degradation which has been localized to the 
lumen of the Pdu MCP is subject to mechanism-based inactivation and requires 
cobalamin recycling for activity (154, 155). This significantly revises our understanding 
of how the Pdu MCP functions. 
The finding that PduS is involved in cobalamin recycling might provide an insight into 
cobalamin reduction in human mitochondria, where the reductive reactions needed for the 
synthesis of AdoCbl are not well understood. AdoCbl is an essential cofactor for the 
mitochondrial methylmalonyl-CoA mutase (MUT or MCM) that converts 
methylmalonyl-CoA to succinyl-CoA during the catabolism of branched-chain amino 
acids, thymine, uracil, cholesterol, and odd-chain fatty acids (76). The current view is that 
cobalamin, probably as cob(II)alamin, is transported into the mitochondria, where the 
second reduction yielding cob(I)alamin occurs followed by adenosylation by human ATR 
to form AdoCbl (17). However, the human mitochondrial cobalamin reductase(s) have not 
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been identified. An earlier study showed that human methionine synthase reductase 
(hMSR) can act as the reducing enzyme in combination with hATR to generate AdoCbl 
from cob(II)alamin in vitro (130). Initially, this suggested that hMSR might function as 
the elusive cobalamin reductase in mitochondria, but, this possibility now seems unlikely 
since a recent report indicates that the hMSR protein is restricted to the cytosol (84). Our 
sequence analyses showed that the Nqo1 subunits of bovine and human mitochondrial 
respiratory complex I have 25% amino acid identity (44% similarity, expect = 8x10-9) to 
the N-terminal region (amino acids 1-165) of the PduS protein of S. enterica. PduS and 
Nqo1 also share SLBB domains, (amino acids 173-221 in PduS) which have 33% amino 
acid identity (expect = 7x10-4) and this domain was proposed to bind cobalamin in the 
PduS protein (46). Moreover, PduS and Nqo1 both contain binding sites for NADH, FMN, 
and an iron-sulfur cluster, involved in electron transfer (Fig. 2B). Although there is 
currently no evidence for a soluble ligand interacting with the SLBB domain in Nqo1, it’s 
possible that cobalamin might bind this domain and accept electrons from Nqo1 given the 
similarity between PduS and Nqo1. Hence, Nqo1 might have dual functions in electron 
transport for a respiratory chain and cobalamin reduction for AdoCbl synthesis, although 
this is speculative at this time. 
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Chapter 3. PduQ is a 1-propanol dehydrogenase associated with the Pdu 
microcompartment of Salmonella enterica 
 
3.1. Abstract 
Salmonella enterica degrades 1,2-propanediol (1,2-PD) using a bacterial 
microcompartment (MCP). The MCP consists of a solid protein shell encasing metabolic 
enzymes such as propionaldehyde dehydrogenase PduP which uses NAD+ as a cofactor. 
In this work, the His6-tagged PduQ protein from S. enterica was produced at high levels 
in Escherichia coli, purified and characterized. PduQ was identified as an iron-dependent 
alcohol dehydrogenase (ADH) that reduces propionaldehyde to 1-propanol with NADH 
as electron donor under physiological conditions although it is able to catalyze the reverse 
reaction as well. Our results also demonstrated that PduQ is a component of Pdu MCPs. 
Genetic studies showed that a pduQ deletion impaired the growth of Salmonella on 
1,2-PD supporting a role in NAD+ regeneration within the MCP in vivo. PduQ is also 
shown to interact with PduP. An N-terminal signal sequence was previously shown to 
direct packaging PduP into Pdu MCPs. Here PduQ might use an alternative packaging 
strategy by which it specifically binds to PduP. 
3.2. Introduction 
Salmonella enterica degrades 1,2-propanediol (1,2-PD) via a coenzyme B12 
(Adenosylcobalamin, AdoCbl) -dependent pathway (110). 1,2-PD is a major product of 
the anaerobic degradation of rhamnose and fucose that are common in plant cell walls, 
bacterial capsules and the glycoconjugates of eukaryotic cells. The ability to degrade 
1,2-PD is thought to provide a selective advantage in anoxic environments such as the 
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large intestines of higher animals, sediments and the depths of soils (138, 163).  
Twenty-four genes specifically involved in 1,2-PD utilization (pdu) are found in a 
single contiguous cluster, the pdu locus (31, 110). This locus consists of the pocR and 
pduF genes as well as the adjacent, but divergently transcribed pdu operon which 
includes 22 pdu genes (pduABB'CDEGHJKLMNOPQSTUVWX). The pdu locus encodes 
a transcriptional regulator (30, 184), a diffusion facilitator (51), enzymes for the 
degradation of 1,2-PD (31, 32, 129, 139, 164) and cobalamin metabolism (31, 74, 112, 
156, 194), as well as proteins for the formation of a bacterial microcompartment (MCP) 
used for 1,2-PD utilization (31, 61, 94, 95, 193).  
Bacterial MCPs are simple proteinaceous organelles used by diverse bacteria to 
optimize metabolic pathways that have toxic or volatile intermediates (28, 48, 53, 245). 
They are polyhedral in shape, 100-150 nm in cross-section (about the size of a large 
virus), and consist of a protein shell that encapsulates sequentially-acting metabolic 
enzymes. Based on sequence analyses, it is estimated that MCPs are produced by 20-25% 
of all bacteria and function in seven or more different metabolic processes (53). The 
function of the Pdu MCP is to confine the propionaldehyde formed in the first step of 
1,2-PD degradation in order to mitigate its toxicity and prevent DNA damage (31, 94, 
193). The Pdu MCP was purified and 15 polypeptide components were identified 
(PduABB'CDEGHJKOPSTU) all of which are encoded by the pdu locus (52, 94).  
A prior study indicated that the pduP gene codes for a lumen propionaldehyde 
dehydrogenase converting 1,2-PD to propionaldehyde using NAD+ as a cofactor (129). 
This raises the question of how NAD+ crosses the MCP shell or/and how NAD+ is 
regenerated within the Pdu MCP. Recent crystallography studies suggested that some 
shell proteins such as PduA, PduT and PduU, may mediate the transport of enzyme 
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substrates/cofactors across the MCP shell (60, 62). However, localized regeneration of 
these cofactors within the MCP might allow more efficient 1,2-PD degradation. 
A recent study indicated that a short N-terminal sequence of some lumen enzymes such 
as PduP efficiently packages the proteins into the Pdu MCP (75). Nevertheless, not all of 
the enzymes located in the MCP possess such a terminal extension. Therefore, other 
mechanism(s) may be applied for protein targeting.  
In this study, PduQ from S. enterica was purified and was identified as an 
oxidoreductase that catalyzes the interconversion between propionaldehyde and 
1-propanol. The result also showed that PduQ is a component of the Pdu MCP. This 
finding suggests that, besides cobalamin (52), the Pdu MCP is able to recycle NAD+ 
internally. In addition, an alternative mechanism for targeting proteins into MCPs was 
proposed based on the interaction between PduQ and PduP. 
3.3. Materials and methods 
Bacterial strains and growth conditions. The bacterial strains used in this study are 
listed in Table 3.1. The rich media used were Luria-Bertani/Lennox (LB) medium (Difco, 
Detroit, MI) (151) and Terrific Broth (TB) (MP Biomedicals, Solon, OH) (226). The 
minimal medium used was no-carbon-E (NCE) medium (25, 233). 
Chemicals and reagents. Antibiotics, cyanocobalamin (CN-Cbl), DNase I, NAD+, 
NADH, NADP+, and NADPH were from Sigma Chemical Company (St. Louis, MO). 
IPTG was from Diagnostic Chemicals Limited (Charlotteville PEI, Canada). PfuUltra 
high-fidelity DNA polymerase was from Stratagene (La Jolla, CA). Taq DNA polymerase, 
restriction enzymes, and T4 DNA ligase were from New England Biolabs (Beverly, MA). 
Other chemicals were from Fisher Scientific (Pittsburgh, PA). 
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TABLE 3.1. Bacterial strains used in this study. 
Species and strain Genotype Source 
E. coli 
BE237 BL21(DE3) RIL/pET-41a Lab collection  
BE272 BL21(DE3) RIL/pTA925-pduP Lab collection 
BE1421 BL21(DE3) RIL/pET-41a-His6-pduP Lab collection 
BE1422 BL21(DE3) RIL/pET-41a-pduP-His6 Lab collection 
BE1500 BL21(DE3) RIL/pET-41a-pduQ This work 
BE1501 BL21(DE3) RIL/pET-41a-His6-pduQ This work 
BE1502 BL21(DE3) RIL/pET-41a-pduQ-His6 This work 
S. enterica serovar Typhimurium LT2 
BE191 ΔpduP Lab collection 
BE269 ΔpduP/pLAC22 Lab collection 
BE270 ΔpduP/pLAC22-pduP Lab collection 
BE287 LT2/pLAC22 Lab collection 
BE903 ΔpduQ::frt This work 
BE919 ΔpduQ::frt/pLAC22 This work 
BE942 ΔpduQ::frt/pLAC22-pduQ This work 
 
Construction of plasmids and a pduQ-deletion mutant. The pduQ gene was 
amplified by PCR (using genomic DNA of S. enterica as the template) then cloned into 
pET-41a vector (Novagen, Cambridge, MA) using NdeI and HindIII restriction sites 
incorporated into the PCR primers as previously described (192). The genes for the 
production of His6-PduQ and PduQ-His6 were similarly cloned with the sequence 
encoding the His6-tag incorporated into either the forward or the reverse PCR primer. The 
resulting plasmids pET-41a-pduQ, pET-41a-His6-pduQ, as well as the 
pET-41a-pduQ-His6 were introduced into Escherichia coli BL21 (DE3) RIL (Stratagene). 
The native pduQ gene was also cloned into pLAC22 (237) between BglII and HindIII 
sites for complementation experiments. Vector pLAC22 allows tight regulation of protein 
production by IPTG (237). All of the above inserts were verified by DNA sequencing.  
The pduQ deletion mutant was constructed by a PCR-based method (64). The deletion 
removed nearly the entire pduQ coding sequence, but left predicted translation signals of 
the adjacent genes (pduP and pduS) intact. The presence of the pduQ deletion was 
verified by PCR as described previously (64) and by genomic DNA sequencing.  
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Phage P22 transduction. Transductional crosses were performed as described using 
P22 HT105/1 int-210, a mutant phage that has high transducing ability (201). 
Transductants were tested for phage contamination and sensitivity by streaking on green 
plates against P22 H5. 
Growth of expression strains and purification of PduQ-His6. Four hundred ml of 
TB containing 25 mg/ml kanamycin was inoculated with 2 ml of BE1502 grown in 
similar medium and the cells were cultivated in a 1 liter baffled Erlenmeyer flask at 37 °C 
with shaking at 275 rpm. When the culture reached an optical density at 600 nm (OD600) 
of about 0.5, 0.5 mM IPTG was added. The culture was incubated for additional 20 h at 
16 °C and 250 rpm shaking. Cells were then harvested by centrifugation at 4 °C and 
6,000 x g for 10 min and used immediately for protein purification under strictly 
anaerobic conditions or under aerobic conditions as previously described except using 
buffer A (50 mM potassium phosphate, pH 8.5, 300 mM NaCl, 5 mM β-mercaptoethanol, 
0.4 mM AEBSF [4-(2-aminoethyl) benzenesulfonyl fluoride-HCl]) at pH 8.5 (52). 
Control strains BE237, BE1500 were grown in parallel with expression strain BE1502 
and similar procedures were used for preparing whole-cell extracts and soluble fractions.  
SDS-PAGE and Western blots. Protein concentration was determined using Bio-Rad 
(Hercules, CA) protein assay reagent with bovine serum albumin (BSA) as a standard. 
SDS-PAGE was performed using Bio-Rad 12% or 10-20% gradient Tris-HCl ready gels. 
Protein bands were visualized by staining with Bio-Safe Coomassie Stain (Bio-Rad). For 
Western blots, the proteins on SDS-PAGE gels were transferred to polyvinylidene 
fluoride (PVDF) membranes and probed using SuperSignal West Pico Chemiluminescent 
Substrate (Pierce, Rockford, IL) according to the manufacturer’s instructions with 
primary rabbit antisera against synthetic peptide ADNRISVFSEITPD (present at 
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positions 51-64 in PduQ of S. enterica) (Genscript, Piscataway, NJ) at the final 
concentration of 0.5 μg/ml and secondary goat anti-rabbit IgG-HRP (Santa Cruz 
Biotechnology, Santa Cruz, CA) at 40 ng/ml. 
Enzymatic activity assays. The catalytic assays were performed under anaerobic 
conditions. All reactions were initiated by addition of NADH or NAD+ to assay mixtures 
except where stated otherwise. Propionaldehyde reduction assays contained 100 mM 
Tris-HCl (pH 7.0), 0.4 mM NADH, 150 mM propionaldehyde and the enzyme as 
indicated in the text. 1-propanol oxidation assays contained 100 mM Tris-HCl (pH 9.0), 1 
mM NAD+, 500 mM 1-propanol and the enzyme. The interconversion between 
propionaldehyde and 1-propanol was monitored spectrophotometrically by measuring the 
absorbance change at 340 nm due to consumption or formation of NADH and quantified 
using Δε340 = 6.22 mM-1 cm-1.  
Metal analysis. The content of Fe in the purified protein was determined by a 
high-resolution double-focusing inductively coupled plasma mass spectrometry (ICP-MS) 
using a Finnigan Element 1 (Thermo Scientific) operated at medium resolution (m/Δm = 
4,000) as described in a prior report (235). Prior to metal analysis samples were applied to 
a Sephadex™ G-25 PD-10 desalting column (GE Healthcare, Piscataway, NJ) 
pre-equilibrated with MilliQ water (resistivity >18 m ) and then were eluted with MilliQ 
water inside an anaerobic chamber or under aerobic condition in order to eliminate 
reagents and metals unbound to the protein. Eluates were collected in metal-free glass 
tubes. Blank water samples, representing the eluates of the Ni-NTA elution buffer 
collected in the same volume range from a parallel PD-10 column, were also analyzed. 
Ga was used as an internal standard to quantify the elemental concentrations of interest. 
Growth studies. Growth studies were performed as previously described (139) with 
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modifications. 2 ml LB broth containing 100 μg/ml ampicillin if needed was inoculated 
with a fresh single colony and incubated overnight at 37 °C with shaking at 275 rpm. 
Cells were collected from the overnight culture by centrifugation at 10,000 x g for 1 min. 
The cell pellet was washed once and resuspended in NCE medium supplemented with 
0.6% 1,2-PD, 1 mM MgSO4, 50 μΜ Ferric citrate, and 0.12 mM each of valine, 
isoleucine, leucine, threonine. The resulting cell suspension was used to inoculate 0.3 ml 
(final volume) of similar medium containing CN-Cbl to an optical density of around 0.1 
at 600 nm. Cultures were grown in 48-well flat-bottom plates (Falcon) at 37 °C with fast 
shaking and OD600 was measured using a Synergy HT Microplate reader (BioTek, 
Winooski, VT). For complementation studies, IPTG was used at 10 μM to induce 
expression of genes cloned into pLAC22. 
Pdu MCP purification. Cells were grown at 37 °C with shaking at 275 rpm to an 
OD600 of 1.0-1.2 in 400 ml NCE medium supplemented with 1 mM MgSO4, 0.5% 
succinate, and 0.6% 1,2-PD inoculated with 2 ml of an overnight LB culture. For strains 
carrying plasmids (pLAC22 or derivatives), the medium additionally contains 100 μg/ml 
ampicillin and 20 μM IPTG. Cells were harvested by centrifugation and washed twice 
with 40 ml buffer B (50 mM Tris-HCl, pH 8.0, 500 mM KCl, 12.5 mM MgCl2, 1.5% 
1,2-PD). Cells were resuspended in 25 ml buffer C [1:1.5 bufferB:B-PER II (Pierce)] 
containing 5 mM β-mercaptoethanol, 0.4 mM ABESF, 25 mg lysozyme, and 2 mg DNase 
I and incubated at room temperature with 60 rpm shaking for 30 min and then on ice for 5 
min. Cell debris was removed by centrifugation twice at 12,000 x g for 5 min at 4 ˚C and 
the MCPs were spun down at 20,000 x g for 20 min at 4 ˚C. The pellet was washed once 
in 10 ml buffer C containing 5 mM β-mercaptoethanol and 0.4 mM ABESF and 
resuspended in 1 ml buffer D (50 mM Tris-HCl, pH 8.0, 50 mM KCl, 5 mM MgCl2, 1% 
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1,2-PD) containing 5 mM β-mercaptoethanol and 0.4 mM ABESF. The remanent cell 
debris was removed at 12,000 x g for 1 min at 4 ˚C for three times. Purified MCPs were 
stored at 4 °C until used. 
MALDI-TOF MS-MS. The tandem mass spectroscopy was performed as previously 
described (52).  
His-tag protein affinity pull-down assays. The soluble cell lysates containing 
recombinant His-tagged protein bait were applied to the pre-equilibrated Ni-NTA column. 
After washing away the unbound proteins with buffer A containing 100 mM imidazole, 
the soluble cell lysates containing recombinant unfused protein prey were loaded onto the 
column where the bait was immobilized. Following washing, the protein-protein 
interaction complex was eluted from the column and was detected by SDS-PAGE. 
3.4. Results 
Sequence analysis. The PduQ protein of S. enterica is composed of 370 amino acid 
residues (31). Over 100 PduQ homologues present in GenBank are associated with 
1,2-PD degradation based on gene proximity. According to the amino acid sequence, 
PduQ of S. enterica belongs to the family of iron-activated group III alcohol 
dehydrogenase (Pfam0456) (178). It has 32% sequence identity (49% overall similarity) 
with the 1,2-propanediol dehydrogenase from E. coli (153), and 34% identity (51% 
overall similarity) with 1,3-propanediol dehydrogenase from Klebsiella pneumoniae 
(143). PduQ also shares 36% identity (52% overall similarity) with the Salmonella 
putative ethanol dehydrogenase EutG involved in ethanolamine utilization (31, 219). 
PduQ possesses conserved binding sites for substrates and cofactors, including an 
NAD-binding motif (89GGG91) and a motif (241GX2HX2AHX2GX5PHG259 where X 
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denotes any amino acid) with conserved Asp175 and His179 involved in Fe-binding (11, 
143, 153) (Fig. 3.1). Although PduQ contains another classic NAD(P)-binding fingerprint 
(13GXGXX[A/G]18) (37), previous studies indicated that this pattern was not conversed or 
involved in binding NAD(P) in group III alcohol dehydrogenase (63, 153).  
 
FIG. 1. Sequence alignment by clustal X2. EcFucO, 1,2-propanediol dehydrogenase from Escherichia 
coli (GI 16130706); KpDhaT, 1,3-propanediol dehydrogenase from Klebsiella pneumoniae (GI 
940440); SeEutG, ethanol dehydrogenase from Salmonella enterica (GI 687647); SePduQ, propanol 
dehydrogenase from S. enterica (GI 5069460). 
Expression and purification of PduQ-His6 protein. E. coli strain BE1502 was 
constructed to produce high levels of C-terminal-His6-tagged PduQ protein via a T7 
expression system. This strain produced relatively large amounts of protein near the 
expected molecular mass of PduQ-His6 (40.3 kDa) (Fig. 3.2). In contrast, cell extracts 
from a control strain containing the expression plasmid without insert (BE237) produced 
much less protein near 40.3 kDa. PduQ-His6 was purified under both aerobic and 
anaerobic conditions by Ni-NTA affinity chromatography. Based on SDS-PAGE 
anaerobically purified PduQ-His6 protein was about 95% homogenous (Fig. 3.2, lane 4), 
and a similar level of purity was obtained for aerobically purified enzyme. 
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FIG. 2. SDS-PAGE analysis of the anaerobic purification of PduQ-His6 from BE1052. Lane 1, protein 
standards; lane 2, 10 μg whole-cell extract; lane 3, 10 μg soluble fraction; lane 4, 2 μg purified 
PduQ-His6. The gel was Bio-Rad 10-20% gradient ready gel and was stained with Coomassie. 
In vitro catalytic activities of the PduQ-His6 enzyme. PduQ-His6 was purified using 
strictly anaerobic conditions and tested for the activities as a propionaldehyde reductase 
and as a propanol dehydrogenase after each purification step (Table 3.2).  
The whole-cell extract from the PduQ-His6 expression strain (BE1502) exhibited about 
23-fold higher propionaldehyde reductase activity (2.8 ± 0.2 μmol min-1 mg-1) than did 
extracts from the control strain carrying the expression plasmid without insert (BE237) 
(0.12 ± 0.03 nmol min-1 mg-1). Purification of the PduQ-His6 protein by anaerobic 
Ni-NTA chromatography increased the propionaldehyde reductase specific activity 
approximately 19.8-fold to 55.5 ± 4.2 μmol min-1 mg-1.  
TABLE 3.2. Anaerobic purification of PduQ-His6. 
Propionaldehyde reductasea Propanol dehydrogenaseb 
Purification step 
Total 
protein 
(mg) 
Specific activity 
(μmol min-1 mg-1) 
Total activity 
(μmol min-1) 
Purification 
fold 
Specific activity 
(μmol min-1 mg-1) 
Total activity 
(μmol min-1) 
Purification 
fold 
Whole-cell extract 403.6 2.8 ± 0.2c 1130 1 0.8 ± 0.1c 322.9 1 
Soluble fraction 246.4 3.1 ± 0.3c 763.8 1.1 0.9 ± 0.2c 221.8 1.1 
Ni-NTA eluate 4.4 55.5 ± 4.2 244.2 19.8 5.1 ± 0.7 22.4 6.4 
abAssayes were performed with 100 mM Tris-HCl at pH 7.0 and pH 9.0, respectively. 
cThe values of the background activities were not subtracted. 
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Assays showed that the PduQ-His6 protein also catalyzed the reverse reaction, 
oxidation of 1-propanol. Whole cell extracts of the expression strain BE1502 had 0.8 ± 
0.1 μmol min-1 mg-1 1-propanol dehydrogenase activity. While control extracts from 
BE237 also exhibited 1-propanol dehydrogenase activity (0.42 ± 0.08 μmol min-1 mg-1). 
Purification of the PduQ-His6 protein by anaerobic Ni-NTA chromatography increased 
the 1-propanol dehydrogenase specific activity about 13.4-fold to 5.1 ± 0.7 μmol min-1 
mg-1.  
The alcohol dehydrogenase(s) in the expression host stain contributed to the values in 
Table 3.2 and displayed relatively high activity and preference for 1-propanol oxidation 
under the tested conditions, which partially accounts for the incongruity of the 
purification folds in two activities of the purified protein. 
PduQ-His6 was also purified under aerobic conditions. Aerobically purified PduQ-His6 
retained about 20% activity, indicating that the enzyme is oxygen-labile.  
The C-terminal His6-tag had no significant effect on PduQ enzymatic activities based 
on the comparisons of the catalytic activities in the whole-cell extracts and soluble 
fractions of BE1502 and BE1500, which respectively express PduQ-His6 and unfused 
PduQ. 
Reaction requirements. To determine the PduQ reaction requirements, key assay 
components were individually omitted. For propionaldehyde reduction, there was no 
activity in the absence of NADH, propionaldehyde, or PduQ-His6. In the propanol 
dehydrogenase assays, no activity was measurable in the absence of NAD+, 1-propanol, 
or PduQ-His6.  
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FIG. 3.3. pH dependence of propionaldehyde reduction and 1-propanol oxidation activities catalyzed 
by PduQ-His6 of S. enterica. The maximal activities for propionaldehyde reduction and 1-propanol 
oxidation were achieved at pH 7.0 and 9.0, respectively. The assasy buffer was 100 mM Tris-HCl. 
Effects of pH on PduQ-His6 activity. The pH optima for PduQ-His6 activities were 
determined in 100 mM Tris-HCl buffer with pH value ranging from 6.0 to 10.0. The 
anaerobically purified PduQ-His6 exhibited maximal activity for propionaldehyde 
reduction at pH 7.0 while the maximal 1-propanol dehydrogenase activity was achieved 
at pH 9.0 (Fig. 3.3), which is consistent with the common feature of pH preference of 
several alcohol dehydrogenases (178).  
Preference for the coenzyme of PduQ-His6. To determine the cofactor specificity of 
PduQ-His6 both catalytic activities were assayed in the presence of either NADH or 
NADPH at 0.4 mM and of either NAD+ or NADP+ at 1 mM. Results showed that 
anaerobically purified PduQ-His6 enzyme had 13% relative activity for propionaldehyde 
redution with NADPH compared to NADH and 11% relative activity for 1-propanol 
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oxidation with NADP+ compared to NAD+, showing that PduQ has a preference for 
NAD(H). 
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FIG. 3.4. Identification of Fe in purified PduQ-His6 using ICP-MS (cps: counts per second). 
Characterization of Fe ion in PduQ-His6. Fe was detected from PduQ-His6 protein 
using ICP-MS (Fig. 3.4). The anaerobically purified PduQ-His6 protein contains 1.01 ± 
0.04 Fe-atom per monomeric unit while the aerobically purified PduQ-His6 protein 
contains 0.18 ± 0.02 Fe-atom per monomeric unit, indicating that iron was lost much 
readily in the presence of oxygen. In addition, the PduQ catalytic activities were almost 
totally inhibited by 1 mM EDTA. In combination with the above results that the 
anaerobically purified PduQ-His6 has much higher enzymatic activity, PduQ is 
iron-dependent and oxygen-labile.  
Linearity of the reactions. The effects of PduQ-His6 concentration on enzymatic 
activities were determined. Propionaldehyde reductase was proportional to PduQ-His6 
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concentration from 10 to 95.5 nM when 0.4 mM NADH and 150 mM propionaldehyde 
were used as substrates. Linear regression yielded an R2 value of 0.9981. Propanol 
dehydrogenase was linear from 0.16 to 1.4 μM PduQ-His6 (R2 = 0.9994) when the assay 
mixture contains 1 mM NAD+ and 500 mM 1-propanol. 
Kinetic analysis of PduQ-His6 activities. Steady-state kinetic studies for 
propionaldehyde reduction and 1-propanol oxidation were performed using anaerobically 
purified PduQ-His6 with varied concentrations of one substrate and a fixed concentration 
of the other substrate. Kinetic parameters were obtained by non-linear curve fitting to the 
Michaelis-Menten equation v = Vmax [S]/(Km + [S]) using GraphPad Prism 5 Software 
(GraphPad Software, San Diego, CA). For propionaldehyde reduction, the apparent Km 
values for NADH and propionaldehyde were 45.3 ± 5.3 μM and 16.0 ± 2.0 mM, 
respectively (Table 3.3). The enzyme Vmax was 77.7 ± 3.0 or 81.3 ± 4.5 μmol min–1 mg–1 
when propionaldehyde or NADH was held at 150 mM and 400 µM, respectively.  
For 1-propanol oxidation, non-linear regression indicated an apparent Km of 267.5 ± 
22.3 μM and 95.8 ± 9.2 mM for NAD+ and 1-propanol, respectively (Table 3.3). The 
enzyme Vmax was 9.2 ± 0.7 μmol min–1 mg–1 or 8.4 ± 0.8 μmol min–1 mg–1 when the 
1-propanol or NAD+ was held at fixed concentrations of 500 mM and 1 mM, respectively.  
TABLE 3.3. Kinetic parameters for propionaldehyde reduction and 1-propanol oxidation by 
anaerobically purified PduQ-His6.  
Reaction Variable substrate Km
a 
(μM) 
Vmaxa 
(µmol min-1 mg-1) 
kcat 
(s-1) 
kcat/Km 
(μM-1 s-1) 
NADH 45.3 ± 5.3 77.7 ± 3.0 52.2 1.15 Propionaldehy
de reductionb propionaldehyde (16.0 ± 2.0 ) x 103 81.3 ± 4.5 54.6 3.41 x 10-3
NAD+ 267.5 ± 22.3  9.2 ± 0.7 6.18 2.31 x 10-21-propanol 
oxidation c 1-propanol (95.8 ± 9.2 ) x 103 8.4 ± 0.8 5.64 5.89 x 10-5
aThe values of Km and Vmax were from non-linear regression using GraphPad Prism 5. 
bc Assayes were performed with 100 mM Tris-HCl at pH 7.0 and pH 9.0, respectively. 
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Phenotype and complementation of a pduQ deletion mutation. To investigate the 
function of PduQ in vivo, we measured the growth of a pduQ deletion mutant (BE903) on 
1,2-PD minimal medium. BE903 grew slowly and to a lower cell density than wild-type S. 
enterica on 1,2-PD minimal medium supplemented with either saturating or limiting 
levels of CN-Cbl (100 or 20 nM) (Fig. 3.5A, B). Complementation analysis was also 
conducted. Production of PduQ from pLAC22 fully corrected the impaired growth 
phenotype of the ΔpduQ mutant at saturating CN-Cbl (Fig. 3.5C) and limiting CN-Cbl 
(not shown) confirming that impaired growth was due to the pduQ deletion, and not due 
to polarity or an unknown mutation. The growth curves shown in Figure 3.5 A-C were all 
repeated at least three times with triplicate cultures. The growth phenotype of the pduQ 
deletion mutant suggests a role for PduQ in NAD+ recycling in vivo as further described 
in the discussion section. 
PduQ is a component of Pdu MCP. To determine the cellular location of PduQ, 
MCPs purified from wild-type S. enterica and pduQ deletion mutant BE903, were 
analyzed by SDS-PAGE and MALDI-TOF MS-MS. A band near the expected molecular 
mass of PduQ (39.5 kDa) was observed on an SDS-PAGE gel of MCPs purified from the 
wild-type strain (Fig. 3.6 lane 2) while absent in MCPs purified from the pduQ deletion 
mutant (Fig. 3.6 lane 3). This band was further analyzed by MALDI-TOF MS-MS. All 
three sequences (MNTFSLQTRL, RFNAGVPRA, RIPAMVQAALADVTLRT) identified 
by MS-MS of a trypsin digest matched the PduQ protein. Western blot using the antisera 
against a small peptide in PduQ also detected a band neat 39 kDa from the purified MCP. 
These results indicated that PduQ protein is a component of Pdu MCPs.  
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FIG. 3.5. Phenotype and complementation of a pduQ deletion mutation. Cells were grown in NCE 
minimal medium with 1,2-PD as a sole carbon and energy source. The pduQ deletion impaired growth 
and decreased cell density on 1,2-PD supplemented with saturating (100 nM) CN-Cbl (A) and limiting 
(20 nM) CN-Cbl (B). The pduQ deletion was complemented by ectopic expression of PduQ induced 
by 10 μM IPTG at 100 nM CN-Cbl (C). 
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FIG. 6. PduQ is a component of the Pdu MCP and disappears in the absence of PduP. 10-20% 
SDS-PAGE gel stained with Coomassie brilliant blue. Lane 1, molecular mass markers; lane 2, 10 μg 
Pdu MCPs purified from wild-type Salmonella; lane 3, 10 μg Pdu MCPs purified from a pduQ 
deletion mutant BE903; lane 4, 10 μg Pdu MCPs purified from a pduP deletion mutant BE191.  
Interaction between PduQ and PduP. The Pdu MCPs purified from the pduP 
deletion mutant BE191 contained much less PduQ protein than those from the wild type 
(Fig. 3.6 lane 4 and 2), suggesting an interaction between PduQ and PduP. To examine the 
potential interaction of PduQ and PduP in vitro, His-tag pull-down assays were performed. 
The following SDS-PAGE demonstrated that unfused PduQ was co-purified with the N- 
or C-terminally His-tagged PduP and unfused PduP was co-purified with the C-terminally 
His-tagged PduQ (Fig. 3.7). Control experiments showed that unfused PduQ and unfused 
PduP could not bind to the Ni-NTA column. These results indicated that PduQ 
specifically interacts with PduP. Worthy of mention is that the unfused PduP was not 
co-purified with the N-terminal-His-tagged PduQ (Fig. 3.7 lane 7), suggesting that the 
N-terminus of PduQ may be involved in the PduQ-PduP interaction. 
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FIG. 3.7. His-tag protein affinity pull-down assays. Lane 1, protein standards; lane 2, His6-PduP; lane 3, 
His6-PduP+PduQ; lane 4, PduP-His6; lane 5, PduP-His6+PduQ; lane 6, His6-PduQ; lane 7, 
His6-PduQ+PduP; lane 8, PduQ-His6; lane 9, PduQ-His6+PduP. 
3.5. Disscusion  
Alcohol dehydrogenases (ADHs) are a family of oxidoreductases that catalyze the 
interconversion between alcohols and aldehydes or ketones, and they are widely 
distributed in virtually all living organisms (178). ADHs can be divided into three classes 
based on their cofactor specificity: (i) NAD(P), (ii) pyrollo-quinoline quinone (PQQ), 
heme or cofactor F420, and (iii) flavin adenine dinucleotide (FAD). The 
NAD(P)-dependent alcohol dehydrogenases are the best-studied class and are generally 
subdivided in three major groups: zinc-dependent long-chain ADHs (group I), 
zinc-independent short-chain ADHs (group II), and the iron-activated ADHs (group III) 
(178). 
The results presented in this report demonstrated that PduQ encoded by the pdu locus 
of S. enterica is an iron-dependent ADH which catalyzes the interconversion between 
propionaldehyde and 1-propanol. The data showed that the propionaldehyde reduction 
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activity was about 45 times higher than that of the 1-propanol oxidation at pH 7.0, 
indicating that this enzyme is more efficient for catalyzing aldehyde reduction in cells 
where approximatedly neutral pH is maintained. Moreover, kinetic data in Table 3.3 
exhibited high catalytic efficiency for the propionaldehyde reduction and high affinity for 
the substrate and cofactor involved in this reaction, which also suggest that the 
physiological function of PduQ is the reduction of aldehyde with the consumption of 
NADH to NAD+.  
To examine the role of PduQ in vivo, we tested the effects of a pduQ deletion mutation 
on AdoCbl-dependent growth on 1,2-PD with saturating or limiting CN-Cbl (Fig. 3.5A, 
B). Under both conditions, the pduQ deletion impaired growth and led to a lower cell 
density, indicating that PduQ was required to support the maximal rate of 1,2-PD 
degradation by Salmonella under the conditions used.  
Within the MCP protein shell, one of the main catabolic enzymes for 1,2-PD utilization, 
propionaldehyde dehydrogenase PduP, catalyzes the reaction of propionaldehyde to 
propionyl-CoA using NAD+ as a cofactor. As a result, the electron carrier NAD+ must 
cross the solid protein shell from the cytosol or/and be regenerated inside the MCPs to 
avoid depletion of the lumenal NAD+. Recent crystallography studies suggested that some 
shell proteins such as PduA, PduT and PduU, may mediate the transport of enzyme 
substrates/cofactors across the MCP shell (60, 62). Nonetheless, localized regeneration of 
cofactors within the MCP might be advantageous for both the activity of the metabolic 
enzymes and the efficiency of 1,2-PD degradation. Our recent study indicates that 
cobalamin, a cofactor for another lumen enzyme diol dehydrogenase PduCDE, is recycled 
within the MCPs (52). In this study, SDS-PAGE of the Pdu MCPs purified from the wild 
type Salmonella (Fig. 3.6) and the following MS-MS analyses demonstrated that PduQ is 
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a component of Pdu MCPs. In conjunction with its in-vitro and in-vivo function and 
properties discussed above, PduQ may serve to help balance redox reactions during 
1,2-PD fermentation by converting a portion of the propionaldehyde to 1-propanol and 
NADH to NAD+, which support the NAD+-recycling mechanism within the MCPs (Fig. 
3.8).  
 
FIG. 3.8. Proposed function of PduQ in NAD+ regeneration inside the Pdu MCPs of S. enterica. The 
dashed line indicates the shell of the MCP. Prior studies showed that propionaldehyde dehydrogenase 
(PduP) resides in the lumen of the Pdu MCP and PduP uses NAD+ as a coenzyme. The MCP lumen 
enzyme PduQ helps recycle the electron carriers and balance redox reactions by converting a portion of 
the propionaldehyde to 1-propanol and NADH to NAD+ to avoid depleting NAD+ within the MCP 
lumen.  
A recent study demonstrated that a short N-terminal signal peptide of some lumen 
enzymes such as PduP can direct packaging proteins into the Pdu MCPs through binding 
specific sites on the interior surface of shell protein assemblies (75). However, the MCP 
lumen enzyme PduQ lacks an obvious packaging signal sequence in comparison with 
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EutG (Fig. 3.1), a PduQ functional counterpart in Eut MCPs involved in ethanolamine 
utilization (219). In this report, the SDS-PAGE of the MCPs purified from the pduP 
deletion mutant only displayed trace amount of PduQ protein (Fig. 3.6 lane 4), and the 
His-tag pull-down assays demonstrated a specific interaction between PduQ and PduP 
(Fig. 3.7). These results suggested an alternative packaging strategy by which some 
lumen enzymes lacking N-terminal signal sequences specifically bind to the 
shell-immobilized proteins that mediate the targeting of these enzymes into the MCPs. 
3.6. Acknowledgements 
This work was supported by NSF grant MCB0956451 to TAB. We thank Megan 
Mekoli and Travis Witte from Dr. Robert S. Houk group in the Department of Chemistry 
at Iowa State University for help with ICP-MS analyses, Siquan Luo from the ISU Protein 
Facility for aid with MS-MS analyses, and the ISU DNA Sequencing and Synthesis 
Facility for assistance with DNA analyses. 
 
 
100 
 
Chapter 4. Conclusions 
A number of enteric and lactic acid bacteria such as S. enterica grow on 
1,2-propanediol (1,2-PD) in a coenzyme B12-dependent fashion (163). 1,2-PD is a major 
product of the anaerobic degradation of the common plant sugars, rhamnose and fucose (2, 
10, 12, 35, 36, 138). The ability to degrade this compound is thought to provide a 
selective advantage in anaerobic environments such as the large intestines of higher 
animals, sediments and the depths of soils. Prior studies have shown that 1,2-PD 
degradation is one of the most complex metabolic processes known. The degradation of 
this small molecule requires an unusual proteinous microcompartment (Pdu MCP) that 
sequesters a toxic metabolic intermediate propionaldehyde (31, 193). The Pdu MCP 
consists of a solid protein shell that encapsulates sequentially-acting metabolic enzymes, 
including the diol dehydratase PduCDE and the propionaldehyde dehydrogenase PduP 
that respectively use AdoCbl and NAD+ as cofactors. During catalysis, the 
adenosyl-group of AdoCbl bound to PduCDE is periodically lost due to by-reactions and 
is usually replaced by a hydroxo-group resulting in the formation of an inactive 
OH-Cbl-enzyme complex (228), and the NAD+ is converted to NADH by PduP (129), 
which makes it necessary to regenerate or/and replenish AdoCbl and NAD+.   
Recent crystallography studies suggested that some shell proteins such as PduA, PduT 
and PduU, have pores that may mediate the transport of enzyme substrates/cofactors 
across the MCP shell (60, 62). However, localized regeneration of these cofactors within 
the MCP might be advantageous for both the activity of the metabolic enzymes and the 
efficiency of 1,2-PD degradation. 
 
Cobalamin recycling within the Pdu MCP 
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The first part of this study (Chapter 2) investigated the bifunctional cobalamin 
reductase PduS. This protein was over-expressed, purified, and characterized including its 
kinetic properties. The results indicated that PduS is a monomer and each monomer of 
PduS contains one non-covalently bound FMN and two [4Fe-4S] clusters. Purified PduS 
enzyme exhibited the ability to reduce cob(III)alamin to cob(II)alamin and cob(II)alamin 
to cob(I)alamin in the presense of a trapping agent in vitro. Genetic studies showed that a 
pduS deletion decreased the growth rate of Salmonella on 1,2-PD supporting a role in 
cobalamin reduction in vivo. Further SDS-PAGE and Western blot of purified Pdu MCP 
and MS-MS analysis demonstrated that the PduS protein is a component of the Pdu MCP. 
In addition, two-hybrid experiments indicated that PduS interacts with the PduO 
adenosyltransferase which is also located in the Pdu MCP and catalyzes the terminal step 
of AdoCbl synthesis.  
The finding that PduS is a MCP protein, establishes that all the enzymes needed for 
cobalamin recycling are components of the Pdu MCP suggesting that cobalamin recycling 
can occur entirely within the lumen of the Pdu MCP: diol dehydratase reactivase PduGH 
releases OH-Cbl from PduCDE; then, OH-Cbl is reduced by PduS to cob(I)alamin and 
adenosylated to AdoCbl by the PduO adenosyltransferase; finally, AdoCbl spontaneously 
associates with apo-PduCDE to form active holoenzyme. The recycling of AdoCbl is 
required to maintain the activity of PduCDE and hence is essential for the degradation of 
1,2-PD as a carbon and energy source. 
 
NAD+ recyling within the Pdu MCP 
The second part of this study (Chapter 3) investigated the 1-pronanol dehydrogenase 
PduQ. This protein was over-expressed, purified, and characterized. PduQ was identified 
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as an iron-dependent alcohol dehydrogenase (ADH) which catalyzes the interconversion 
between propionaldehyde and 1-propanol. However, the propionaldehyde reduction 
activity of PduQ was about 45 times higher than that of the 1-propanol oxidation at pH 
7.0, indicating that this enzyme is more efficient for catalyzing aldehyde reduction in cells 
where approximatedly neutral pH is maintained. Moreover, kinetic data exhibited high 
catalytic efficiency for the propionaldehyde reduction and high affinity for the substrate 
and cofactor involved in this reaction, which also suggest that the physiological function 
of PduQ is the reduction of aldehyde with the consumption of NADH to NAD+.  
Silmilar to PduS, SDS-PAGE and Western blot of purified Pdu MCP and subsequent 
MS-MS analysis demonstrated that the PduQ protein is also associated with the Pdu MCP. 
To examine the role of PduQ in vivo, the effects of a pduQ deletion mutation on 
AdoCbl-dependent growth on 1,2-PD were tested and the results showed that the pduQ 
deletion impaired growth and led to a lower cell density, indicating that PduQ was 
required to support the maximal rate of 1,2-PD degradation by Salmonella. Furthermore, 
the His-tag pull-down assays demonstrated a specific strong interaction between PduQ 
and PduP.  
All these results support that the MCP lumen enzyme PduQ helps recycle the electron 
carriers and balance redox reactions by converting a portion of the propionaldehyde to 
1-propanol and NADH to NAD+ to avoid depleting NAD+ within the MCP lumen. 
 
A model for the Pdu MCP 
In addition, the phosphotransacylase PduL is also associated with the Pdu MCPs, 
which was confirmed by Western blot. Thus, the Pdu MCPs encapsulate the enzymes 
needed to regenerate the cofactors required by other enzymes encased within the protein 
 
 
103 
 
 
shell although these cofators may also cross the shell. PduGH, PduO, and PduS constitute 
the AdoCbl recycling system; PduQ (perhaps with PduS) functions in NAD+ recycling; 
and PduL regenerates CoA; which are able to support the maximal degradation of 1,2-PD 
by Salmonella (Fig. 4.1). 
   
FIG. 4.1. The Pdu MCPs regenerate enzymatic cofactors internally. The MCP protein shell is indicated 
by the dashed line. The PduGH, PduO, and PduS constitute the AdoCbl recycling system; PduQ 
(perhaps with PduS) functions in NAD+ recycling; and PduL regenerates CoA; which are able to 
support the maxmal degradation of 1,2-PD by Salmonella.
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